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ABSTRACT 
 
The study sought to determine the meaning and interpretation by facility managers and 
nurses on utilisation of expanded programme on immunisation and integrated 
management of childhood illnesses (EPI and IMCI) programmes for follow-up and 
antibody testing of HIV-exposed infants (HEI) at 18 months. Also to understand the 
factors within the health systems that influence the follow-up and antibody testing. The 
study setting selected was six facilities in Steve Tshwete subdistrict in Nkangala district 
of Mpumalanga province in South Africa. 
 
The study used a hermeneutic phenomenology using in-depth interviews for collecting 
data from 4 facility managers and 12 nurses. The major themes that emerged from the 
interviews were referral, defaulting, integration, stigma, and off-site ART initiation within 
the health system. These were found to influence the utilisation of HEI and IMCI 
services for follow-up and management of HEI. It was also found that the importance of 
integrating the management of HEI into the EPI and IMCI cannot be overemphasised. It 
was concluded that the Health Department needs to be vigilant and use all available 
resources to manage HEI to meet the MDG 4 of prevention of infant mortality. 
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CHAPTER 1 
 
OVERVIEW OF THE STUDY 
 
1.1 INTRODUCTION  
 
In 2011, the South African Department of Health (DOH) (2011c:14) introduced the 
National Human Immunodeficiency Virus (HIV), Acquired Immune Disease Syndrome 
(AIDS) and Sexually Transmitted Infections (STIs) Strategic Plan, 2012-2016 stating 
that the rate of positive Deoxyribonucleic acid (DNA) polymerase chain reaction (PCR) 
test taken at 6 weeks on HIV-exposed infants (HEI) should be below 2% and the 
antibody test of babies at 18 months should be below 5% by 2016. Furthermore, 
management and leadership should be strengthened to coordinate the prevention of 
mother-to-child transmission (PMTCT) of HIV programme and ensure its integration with 
maternal and child health programmes.  
 
The millennium development goal (MDG) 4 is aimed at reducing the infant mortality rate 
by two thirds by 2015 (United Nations International Children's Emergency Fund 
[UNICEF] 2007:17). Regarding MDG 6, in his report on “Children and the millennium 
development goals”, the Secretary General of the United Nations, Ban Kin Moon, said 
the emergence of HIV and AIDS was a sudden reminder of human vulnerability in an 
increasingly globalised world. Further health threats inevitably lie in wait demanding 
constant vigilance and stronger and more extensive forms of international cooperation 
that can generate swift and effective responses (UNICEF 2007:84). This is a call for all 
countries including South Africa to take action. Health researchers need to undertake 
studies that will look into effectiveness in systems and factors that will influence 
cooperation in response to the call.  This should be at all levels from smaller units like 
facilities up to international.  
 
In a study in Malawi on mortality and health outcomes of HIV-exposed and -unexposed 
children in a PMTCT cohort, Landes, Van Lettow, Chan, Mayuni, Schouten and Bedell 
(2012:6) found a high mortality at 20 months among HIV-exposed children. Although 
Landes et al (2012:6) reported a low uptake of early diagnosis, their results indicate 
high mortality at 20 months among HIV-exposed infants (187 deaths/1000 livebirths), 
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consistent with a meta-analysis in sub-Saharan Africa (SSA) reporting a cumulative 
mortality rate of 174/1000 livebirths among HIV-exposed children at 24 months. 
 
 Literature studied will illustrate that mortality is still high in HIV-exposed than 
unexposed children in South Africa. The PMTCT clinical guideline (DOH 2009:35) 
stipulates that HIV-exposed infants should be followed up at least monthly in the first 
year of life and every three months thereafter, regardless of their method of feeding. 
Infants clinically suspected of having HIV should be tested for HIV, regardless of their 
age. The researcher will illustrate in the study the significance of following this guideline 
for prevention of infant mortality. 
 
The South African Expanded Programme on Immunisation (EPI) schedule stipulates 
that all children should be immunised at 6, 10 and 14 weeks, and at 9 and 18 months. 
All HIV-exposed infants (HEI) not on ART should have a rapid HIV test at 18 months of 
age (DOH 2009:35).  The relationship and linkage between EPI and management of 
HEI will be illustrated as the study unfolds. 
 
In this study, therefore, the researcher sought to determine the meaning and 
interpretation by facility managers and nurses on utilisation of EPI and IMCI 
programmes for follow-up and antibody testing of HIV-exposed infants (HEI) at 18 
months in Steve Tshwete of Nkangala district in Mpumalanga province in South Africa. 
 
1.2 BACKGROUND INFORMATION 
 
1.2.1 Global view of child mortality linked to HIV exposure 
 
In his foreword on the report on the children and the MDGs, Ban Kin Moon, Secretary 
General of the United Nations (UNICEF 2007: v) acknowledges that much has been 
done to work towards realising the MDGs. He also cautions, however, that a lot still 
needs to be done. It is evident in his report that prevention of mother-to-child 
transmission (PMTCT) of HIV is the cornerstone to realising MDG 4 and 6 on two thirds 
reduction of infant mortality and combating HIV and AIDS, respectively (UNICEF 
2007:79). The 2012 child mortality report indicates that child mortality in the sub-
Saharan region, of which South Africa is part, is still very high. Only 30% of the 
expected reduction has been achieved (UN 2012:26). 
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The 2011 UNICEF report on trends in mortality shows that the highest rates of child 
mortality are still in sub-Saharan Africa where one in eight children dies before the age 
of five (UNICEF 2011:1). According to the report, this is more than seventeen times the 
average for the developed regions where the rates are one in a hundred and forty-three. 
In Asia, the rates are one in fifteen, which is still lower than the sub-Saharan rates 
(UNICEF 2011:1). Although HIV infection has shown some decline as a cause of death, 
it is still one of the causes of death in the sub-Saharan region (UNICEF 2011:5).  
 
1.2.2 HIV-exposed babies in South Africa 
 
South Africa has a comprehensive guideline on PMTCT which takes the mother from 
before pregnancy up to when the baby is eighteen months old. According to the 
guideline, the mother, if positive, is initiated on prophylaxis ARVs or long-life ARVs 
depending on what she qualifies for (DOH 2013a:7). In a previous chapter follow up of 
an HIV exposed infant was specified (DOH 2013a:11). 
 
The EPI schedule (DOH 2010) ensures that the baby visits the health facility at six to 
eight weeks and eighteen months, among other times. The integrated management of 
childhood illnesses (IMCI) for high HIV settings booklet guides frontline workers in 
primary health care (PHC) settings to check for HIV infection in all babies and their 
mothers (WHO 2008:20). This is to ensure opportunities are not missed. The IMCI 
adopted by the South African Department of Health in 2011 also guides nurses to use 
the opportunity for counselling the mother so they can exclude HIV in the baby. 
 
1.2.3 Identification of HIV-exposed children in Nkangala district in Mpumalanga 
province 
 
Although the HIV prevalence in South Africa is stabilising according to the 2011 
antenatal survey, the Mpumalanga province prevalence rose from 35.1% to 36.7% 
(DOH 2012a:15). Although Nkangala district is the lowest of the three Districts in 
Mpumalanga with prevalence, in the child problem identification programme (CPIP 
presentation), available data illustrated that HIV-exposed infants are admitted to 
paediatric units with unknown status, and some die. Accordingly, the study wished to 
determine the meaning and interpretation by facility managers and nurses on utilisation 
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of EPI and IMCI programmes for follow-up and antibody testing of HIV-exposed infants 
(HEI) at 18 months.   
 
1.2.4 Study setting 
 
The setting for qualitative research is the field which is the place where the individuals 
live or work and experience life (Streubert & Carpenter 2011:27). In hermeneutic 
phenomenology, the setting is the world as lived by the participant and not as a 
separate entity (Laverty 2003:4). 
 
Steve Tshwete is one of the six sub-districts of Nkangala district of Mpumalanga 
province in South Africa (Fig1.1). The population pyramid of Steve Tshwete shows a 
high population in the working class age group 20-39 years (DOH 2012d:23). These are 
also a child-bearing group. The relatively large economies of Steve Tshwete and the 
other sub-districts of Emalahleni sustain the economy of Nkangala to a great extent and 
are based on the steel industry, with a high reliance on the manufacturing sector. 
Working mothers in most cases leave the care of their children to carers who have to 
take them to health services for care and treatment. This might impact on the follow up 
of babies in the facilities. 
 
Six facilities in Steve Tshwete were purposively selected based on the EPI and IMCI 
services provided. Of the facilities providing EPI and IMCI, a multistage cluster sampling 
was done to include facilities at township, farming (rural) and city level. This was to 
incorporate meaning and interpretation by facility managers and nurses from different 
areas providing EPI and IMCI programmes for follow-up and antibody testing of HEIs. 
The facilities selected were agreed upon with the sub-district management. 
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Figure 1.1 Map of the Nkangala district municipality in relation to the province 
(Adopted from the DOH 2012d:18) 
 
1.3 PROBLEM STATEMENT 
 
Although more than 90% of babies born of HIV-positive mothers in Steve Tshwete have 
their PCRs done at six weeks of birth that is not the case with antibody testing at 18 
months (DOH 2012b:23). The results of the child problem identification programme 
(CPIP) illustrate that many babies born of HIV-positive mothers were admitted to the 
paediatric units in the local hospital with HIV-related ailments.  This was in spite of the 
fact that South Africa has some of the best guidelines for EPI and IMCI.  
 
There is no clear indication on how these guidelines complement each other. The 
factors in the health systems that affect the utilisation of EPI and IMCI for follow-up and 
antibody testing of the HEI are not clearly documented. Against this background, the 
researcher proposed to undertake a hermeneutic phenomenological enquiry on the 
meaning and interpretation by facility managers and nurses on utilisation of EPI and 
IMCI programmes for follow-up and antibody testing of HEIs at 18 months in Steve 
Tshwete sub-district of Nkangala in Mpumalanga province, South Africa.  
 
1.4 AIM OF THE STUDY 
 
The aim of a study in nursing is to answer questions or solve problems of relevance to 
the nursing profession (Polit & Beck 2008:19).  This could be to answer nursing 
practice, nursing education or nursing management.  
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1.4.1 Purpose of the study 
 
The purpose of this study was to determine the meaning and interpretation by facility 
managers and nurses in the utilisation of EPI and IMCI programmes for follow-up and 
antibody testing of HEIs at 18 months in the Steve Tshwete sub-district of Nkangala in 
Mpumalanga province, South Africa. 
 
1.4.2 Research question 
 
The study wished to answer the following question: 
 
What is the meaning and interpretation of factors affecting utilisation of EPI and IMCI for 
follow up and HIV testing of HEI in the Steve Tshwete sub-district facilities as perceived 
by the nurses? 
 
1.4.3 Research objectives 
 
The objectives of this study were to: 
 
• Have an understanding of available services in the facilities selected for the 
study. 
• Determine the meaning and interpretation as experienced by facility managers 
and nurses of the utilisation of EPI and IMCI programme for follow-up and 
antibody testing of HEIs at 18 months. 
• Define the systems and factors influencing follow-up and management of HEIs 
as experienced by EPI and IMCI facility managers and nurses. 
 
1.5 SIGNIFICANCE OF THE STUDY 
 
The findings from this study will assist the frontline workers to gain knowledge in the 
management of the HEIs. The babies themselves will be managed effectively while the 
Department of Health can improve the services as well as guidelines to accommodate 
the target community. The increased body of knowledge will also assist in health 
education to both staff and patients to ensure that management of these babies is 
strengthened. 
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1.6 RESEARCH DESIGN AND METHODOLOGY 
 
The study was a qualitative phenomenological, interpretive, hermeneutic enquiry. Data 
was collected by means of in-depth interviews in order to acquire an understanding of 
and interpret the phenomenon under study (see chapter 3 for detailed discussion of the 
research design and methodology). 
 
1.7 SCOPE OF THE STUDY 
 
The scope of the study was limited to the six facilities selected in Steve Tshwete sub-
district in Nkangala district of Mpumalanga province. EPI and IMCI services were 
chosen primarily because they form the basis for paediatric care and general child 
health services and their service provision in those selected facilities are such that they 
are the suitable setting for the study. The scope of the study was further to define the 
parameters and focus of HEI within these services. The information was gathered 
through interviewing the facility manager and nurses working in the EPI and the IMCI 
service points. The data was analysed and interpreted and the final results presented 
(Streubert & Carpenter 2011:92).  
 
1.8 DEFINITION OF KEY TERMS  
 
For the purposes of this study, the following key terms are used as defined below. 
 
Expanded programme on immunisation (EPI). A South African Department of Health 
programme which specifies that all babies at 6, 10, and 14 weeks, and at 9 and 18 
months,  should be immunised (DOH 2010:35). 
 
HIV-exposed infant. Infant born to an HIV-positive woman (DOH 2010:5).  A child born 
to an HIV-infected mother but without a confirmed HIV infection or a child exposed to 
infected blood products without confirmed HIV infection. 
 
Integrated management of childhood illnesses (IMCI). The IMCI is a systematic 
approach to children's health which focuses on the whole child and includes curative as 
well as preventive care. The approach was developed by the United Nations Children's 
Fund and the World Health Organization in 1992 (WHO 2008:20). 
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Mother-to-child transmission. Transmission of HIV from an HIV-positive woman to 
her child during pregnancy, delivery, or breastfeeding. The term is used because the 
immediate source of the infection is the mother, and does not imply blame on the 
mother (DOH 2013a:5). 
 
Infant mortality rate (IMR). This refers to the probability of dying between birth and 
exactly one year of age expressed per 1,000 live births (Joubert & Ehrlich 2007:2). 
 
Prevention of mother-to-child transmission (PMTCT) of HIV. The PMTCT is a 
programme that aims to reduce maternal transmission of HIV to babies. It reaches out 
to all women before and during pregnancy, during labour and delivery, and through 
postnatal up to a period of 18 months (DOH 2013a:5). 
 
How does this study define these concepts? 
 
For the purpose of the study, the concepts are used as defined in the definitions. 
 
1.9 STRUCTURE OF THE DISSERTATION 
 
The dissertation is divided into five chapters. 
 
Chapter 1 introduces the research topic; outlines the background to the study; describes 
the setting, purpose, objectives and significance; briefly describes the design and 
methodology, scope and limitations of the study, and defines key terms. 
 
Chapter 2 describes the literature review undertaken on South Africa and other 
countries in relation to utilisation of EPI and IMCI services for the management of HIV- 
exposed babies up to 18 months. 
 
Chapter 3 describes the research design and methodology. 
 
Chapter 4 presents the data analysis and interpretation, and the results. 
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Chapter 5 concludes the study, briefly describes its limitations, and makes 
recommendations based on the findings. 
 
1.10 CONCLUSION 
 
This chapter introduced the study on the utilisation of EPI and IMCI programmes for 
follow-up and antibody testing of HEIs in Steve Tshwete sub-district of Nkangala district 
in Mpumalanga province. The researcher outlined the background to the study, the 
purpose and objectives, research design and methodology, scope and significance of 
the study.  
 
Chapter 2 discusses the literature review conducted for the study.  
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CHAPTER 2 
 
LITERATURE REVIEW AND THEORETICAL FRAMEWORK 
 
2.1 INTRODUCTION 
 
Chapter 1 described the background to, purpose and significance of the study. This 
chapter discusses literature review conducted for the study. 
 
Creswell (2009:25) cites Cooper (1984) and Marshall and Rossman (2006), who state 
that a literature review shares the results of other studies that are closely related to the 
current study and relates the study to a larger on-going dialogue about a topic. The 
literature review also gives academic views on the topic under examination. There is no 
consensus on whether one should do a literature review before a study. Polit and Beck 
(2008:105), however, point out that, researchers rarely conduct research in an 
intellectual vacuum. As the study is interpretive phenomenology, the researcher 
presents an evaluative report on the literature related to the study that was reviewed. 
 
This chapter outlines the literature reviewed for the purpose of the study. The review 
covered international management of HEIs for a contextual background; the PMTCT, 
especially the paediatric aspect thereof in relation to the systems entrenched in the EPI 
and IMCI services. It also looked at infant mortality globally in relation to South Africa 
and Mpumalanga, bringing it down to Steve Tshwete sub-district in Nkangala district. 
Further, it looked at the Government response to the prevention of mother-to-child 
transmission of HIV, and factors influencing the utilisation of the EPI and IMCI services 
in follow-up and management of HEI in other countries. The purpose of this chapter was 
therefore to enhance understanding of the subject and results of related studies. 
 
2.2 PROVIDER INITIATED COUNSELLING AND TESTING (PICT) IN 
PAEDIATRICS 
 
In a study in Nigeria, Babatunde, Ogunbosi, Regina, Oladokun, Biobele, Brown, 
Kikelomo and Osinusi (2011:6) found that the Provider Initiated HIV Testing and 
Counselling (PITC) is useful in identifying HIV infection in patients presenting to health 
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facilities who do not have the classical symptoms and signs of the infection, thereby 
limiting missed opportunities for early detection and care. The findings indicated that of 
children without the classical features of HIV Infection, 17 (3.1%) were found to be 
seropositive for HIV infection, and 10 (1.8%) were confirmed positive for retroviral 
infection.  
 
Babatunde et al’s findings (2011:6) confirm the need to offer routine screening to all 
children presenting in health facilities; identify HIV-infected children early to reduce 
morbidity and mortality; expand access to PMTCT services; ensure implementation of 
PITC in paediatric settings, and expand support services for HIV-infected children. This 
is in line with the PMTCT guideline (2009:35) which also stipulates follow up and HIV 
testing of HIEs. 
 
2.3 STIGMA AND DISCRIMINATION  
 
In their study in Zimbabwe, Buzdugan, Watadzaushe, Dirawo, Mundida Langhaug, Willi, 
Hatzold, Ncube, Mugurungi, Benedikt, Copas and Cowan (2012:7) concluded that HIV 
testing is the essential gateway to prevention and care services for children. The data 
indicated positive attitudes to testing children in Zimbabwe. The study nevertheless 
found that positive attitudes to medical procedures do not always concretise as high 
uptake (as is the case for male circumcision as an HIV preventive method). Hence, 
there is a need to better understand the barriers to paediatric testing, such as stigma 
and discrimination, and address the gaps in knowledge regarding HIV/AIDS in children.  
 
2.4 POLICY ON PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV  
 
In South Africa, the DOH (2009:35) stipulates that HIV-exposed infants should be 
followed-up at least monthly in the first year of life and every three months thereafter, 
regardless of their method of feeding. Infants clinically suspected of having HIV should 
be tested for HIV at 6, 10 and 14 weeks, and at 9 and 18 months; all children should be 
immunised according to the Expanded Programme on Immunisation (EPI) schedule, 
and all HIV-exposed infants not on ART should have a rapid HIV test at 18 months of 
age (DOH 2009:35). The 18 months test is for HIV exposed infants on breastfeeding 
who had a negative PCR test at 6 weeks. The other HIV tests in between are for babies 
who are suspected of HIV due to clinical presentation. 
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Despite these efforts, the PMTCT programme had not delivered according to 
expectation and there was a need to strengthen it. As of March 2009, MTCT proportions 
varied widely across the country, averaging at 12% nationally but with some districts 
reporting MTCT proportions of above 20% (DOH 2009). This was higher than the 
transmission rate of less than 5% expected from a well-functioning PMTCT programme 
and the stipulated target in the NSP for HIV and AIDS and STIs, 2007-2011. To address 
this problem, a plan to accelerate the PMTCT programme was initiated. 
 
2.4.1 Prevention of mother-to-child transmission of HIV accelerated plan 
 
The PMTCT accelerated plan was initiated in 2009 as a focused plan of implementation 
and was part of the National PMTCT programme operational plan. The main objective 
of the plan was to accelerate implementation of PMTCT services to reduce Mother-to-
child transmission of HIV to less than 5% by 2011 in 18 priority districts by: Increasing 
access (demand) to PMTCT services through coordinated social mobilisation strategies; 
implementation of tested and proven models of quality improvement to ensure delivery 
of quality PMTCT services at health care facilities. 
 
The main aim was to scale-up access and improve quality of PMTCT services to reduce 
MTCT as per the NSP for HIV/AIDS and STIs 2007-2011. In the next paragraph, the 
outcome of the aim will be addressed. It was further to integrate the PMTCT programme 
into the existing maternal and child health interventions, such as basic ante-natal care 
(BANC), integrated management of childhood illnesses (IMCI), expanded programme 
on immunisation (EPI) and sexual and reproductive health (S&RH). This was also to 
ensure that mothers living with HIV and their babies are appropriately referred to HIV 
and AIDS services for continued treatment, care and support (DOH 2009). The 
Accelerated Plan or the A plan was a way of accelerating reduction of MTCH. 
 
Though the A plan resulted in a great improvement in the outcomes, Mpumalanga still 
had one of the highest rates after the Eastern Cape according to a study to evaluate the 
effectiveness of PMTCT in South Africa.  The study illustrated that in Mpumalanga 
babies PMTCT born of HIV positive mothers had a PCR positivity rate of 5,7% at 6 
weeks while those of mothers who said they were not HIV positive had a rate of 7,8% 
(Goga, Dinh & Jackson 2012:31). This creates a need to understand the factors that 
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influence the integration of PMTCT into other programmes, especially Paeds HIV 
management into EPI and IMCI.  
 
With the advancement in management of HIV in South Africa, in 2011, the Government 
and different stakeholders developed the National HIV and AIDS and STIs strategic 
plan (NSP), 2012-2016. In this plan the infection rate for PCR test at 6 weeks should be 
below 2% and the HIV antibody rate at 18 months should be below 5%. This is seen as 
a way of revitalisation of prevention of mother-to-child transmission. The 2013 PMTCT 
guideline re-emphasises this in relation to paediatric HIV management. 
 
During a programme review on 15 March 2012 in the Mpumalanga Province data 
illustrated that Nkangala district performance in infant antibody testing uptake at 18 
months was: Quarter 1: 20.3%; Quarter 2: 21.5%, and Quarter 3: 18.3%, with an 
average of 20.3%. This was against a national target of 30%. In some of the Steve 
Tshwete sub-district facilities, there was no data in that period for antibody testing at 18 
months. However, even though no babies were tested in those facilities, the 18 month 
EPI numbers were high. 
 
2.4.2 Infant mortality in South Africa and other countries 
 
The 2011 UNICEF report on trends in mortality indicates that the highest rates of child 
mortality are still in sub-Saharan Africa where one in eight children dies before the age 
of five. The report indicates that this is more than seventeen times the average for 
developed regions where the rates are one in a hundred and forty three. In Asia the 
rates are one in fifteen, which is still lower than the sub-Saharan rates (UNICEF 
2011:1). Although HIV infection has shown some decline as a cause of death, it is still 
one of the causes of death in the sub-Saharan region (UNICEF 2011:5).   
 
Maternal, perinatal and under-5 mortality in South Africa remains unacceptably high. 
According to the Department of Health’s November 2011 Report of the Health Data 
Advisory and Coordination Committee, the figures for Maternal Mortality Ratio, Under-
five, Infant and Neonatal Mortality Rate are 310/100000, 56/1000, 40/1000 and 14/1000 
live births, respectively. South Africa modified the CARMMA campaign of the African 
Union Commission which focuses on maternal mortality and included under 5 mortality, 
where it is cited that the 2015 MDG target for Maternal Mortality Ratio and under-five 
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mortality rate is 38/100000 and 20/1000 live births based on 1998 Demographic and 
Health Survey baseline of 150/100000 and 59/1000 live births, respectively (DOH 
2012:7). 
 
In addition, it is important to understand that reduction of maternal and under-five 
mortality is one of the key goals of the Millennium Declaration (UNAIDS 2008:12). The 
infant mortality rate (IMR) in South Africa in 2009 was estimated at 44 per 1000 live 
births compared to Mexico where it was 18 and Brazil 23 per 1000 live births, 
respectively (UNAIDS 2012:26). 
 
The relevance of the infant mortality situation to the study is that unless we follow up 
HIV-exposed infants, identify and treat those that become positive, we will not meet the 
MDG 4 and 6. 
 
2.4.3 Infant mortality in Steve Tshwete in Nkangala district 
 
Although the HIV prevalence is stabilising in South Africa according to the 2011 
antenatal survey, the Mpumalanga province prevalence rose from 35.1% to 36.7% 
(DOH 2012:15). Nkangala district is the lowest of the three with prevalence, yet the child 
problem identification programme (CPIP presentation) illustrates that HIV- exposed 
infants are admitted to paediatric units in the district with unknown status and some die. 
In this study the researcher seeks to describe the factors within the health systems in 
the six selected facilities that have an effect on the utilisation of the EPI and the IMCI 
programmes for follow-up and antibody testing of HEI at 18 months as perceived by the 
nurses in these facilities 
 
During the provincial quarterly programme review held on 15 March 2012 in 
Mpumalanga, the presentations showed that Nkangala in Mpumalanga had the highest 
infant mortality rate in relation to other districts and provinces (see table 2.1).  This 
supports the CPIP findings.  
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Table 2.1 Nkangala infant mortality rate, 2011/2012 Q1 to Q4  
 
 Baseline Q1 Q2 Q3 Q4 Average 
Nkangala 37.5/1000 32 37.4 57.2 35.9 44.2 
District 2 31.5/1000 29 29.0 26.4 34.6 29.8 
District 3  No data 33.7 27.8 34.0 31.8 
 
(Source: Mpumalanga Department of Health 2012b) 
Key: Q = Quarter 
 
2.5 PMTCT WITH THE EMPHASIS ON HIV-EXPOSED INFANTS AND THEIR 
MANAGEMENT 
 
As literature will illustrate, there seems to be a strong relationship, relevance, 
importance of issues, and implicit connection between ideas in health systems 
strengthening, and factors affecting the utilisation of EPI and IMCI services in the 
management of HEI (WHO 2007:v). There is a need to have a sound understanding of 
factors affecting the utilisation of these services in the management of HEI within the 
systems in the existing paediatric services. Global, national, provincial, district and sub-
district literature illustrate what has been done in response to the HIV infection with the 
emphasis on prevention of mother-to-child transmission and management of HIV- 
exposed infants. 
 
2.5.1 Global perspective on management of HIV-exposed babies 
 
In his foreword to the report on the children and the MDGs, Ban Kin Moon, Secretary 
General of the United Nations (UNICEF 2007:v) acknowledges that much has been 
done to work towards realising the MDGs, but cautions that a lot still needs to be done. 
The report stresses that prevention of mother-to-child transmission (PMTCT) of HIV is 
the cornerstone to realising MDG four and six on two thirds reduction of infant mortality 
and combating HIV and AIDS, respectively (UNICEF 2007:79). The 2012 report 
indicates that child mortality in the sub-Saharan region, of which South Africa is part, is 
still very high. Only 30% of the expected reduction has been achieved (UN 2012:26). 
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The 2011 UNICEF report on trends in mortality shows that the highest rates of child 
mortality are still in sub-Saharan Africa, where one in eight children dies before the age 
of five. The report emphasises that this is more than seventeen times the average for 
developed regions where the rates are 1:143.). Although HIV infection has shown some 
decline as a cause of death, it is still one of the causes of death in the sub-Saharan 
region (UNICEF 2011:5).  
 
In a Malawi study on mortality and health outcomes of HIV-exposed and -unexposed 
children in a PMTCT cohort, Landes, Van Lettow, Cha, Mayuni, Schouten and Bedell 
(2012:6) found a high mortality at 20 months among HIV-exposed children. The study 
found a low uptake of early diagnosis, although there was still a high mortality in HIV-
exposed babies.  The researchers concluded that infant and child mortality could be 
dramatically reduced through effective PMTCT coupled with treatment of maternal HIV 
infection. This addresses not only vertical transmission of HIV but the effect of maternal 
health (and survival) on infant health and survival.  This is inherent in the South African 
guidelines on PMTCT. 
 
2.5.2 South African (including Nkangala district) perspective on management of 
HIV-exposed babies 
 
Chapter 1 discussed the targets set in the NSP. Some successes have been 
experienced in PMTCT since the roll-out of the previous NSP, 2007-2011, hence the 
lowering of the targets in the 2012-2016 NSP. The targets have been reduced for 6 
week-old babies from below 5% positivity to below 2% positivity and a new target for 
HIV positivity on 18 months babies to below 5% positivity. The strategy is working 
towards reducing infections due to vertical transmission to zero (DOH 2011a:12).  This 
is also in line with the MDG 4. 
 
Furthermore, management and leadership should be strengthened to coordinate the 
prevention of mother-to-child HIV transmission (MTCT) programme and ensure its 
integration with maternal and child health programmes (see section 2.8 for discussion 
on the relationship between systems theory, PMTCT, IMCI, and EPI in response to 
MDG4). 
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2.6 INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESSES 
 
The Integrated Management of Childhood Illness (IMCI) strategy was launched in 1996 
by the World Health Organization (WHO) and UNICEF to reduce under-five mortality 
(WHO 2008:1), particularly from pneumonia, diarrhoea, measles, malaria and 
malnutrition. The IMCI has three main components: (1) improving health worker 
performance through training of first-level facility workers and a follow-up visit within 1 
month after training to reinforce the application of new skills in the health worker’s 
environment; (2) improving health system support to IMCI through efforts to ensure drug 
and vaccine availability, strengthen supervisory activities, increase access to and quality 
of care in referral facilities and build administrative support for IMCI at national and 
district levels, and (3) improving family and community practices related to child health 
and development. 
 
In a study on the achievements and challenges in scaling up IMCI to national level in 
Peru, researchers: Huicho, Da´Vila, Campos, Drasbek, Bryce and Victora (2005:21) 
found that the scarcity of data on child health programme implementation at district level 
in Peru cannot be attributed entirely to the national or district programmes. Considerably 
more data, of better quality, was available for other child health programmes, such as 
EPI. A contributing factor may be that the generic guidelines for implementing IMCI 
contain relatively few concrete recommendations for how implementation, including 
training coverage or quality, should be monitored, or how the resulting information can 
be used to improve programme performance. 
 
Gouws, Bryce, Habicht, Amaral, Pariyo, Schellenberg and Fontaine (2004:513) found 
that IMCI case-management training can improve the use of antimicrobial drugs 
significantly among health workers who treat sick children in first-level outpatient health 
facilities in low- and middle-income countries. IMCI-trained health workers were more 
likely than their colleagues who had not had training in IMCI to prescribe antibiotics and 
antimicrobials correctly, and to communicate effectively to caregivers.  In this study, the 
researcher based some of the arguments on these findings. 
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2.7 EXPANDED PROGRAMME ON IMMUNISATION  
 
The WHO initiated the expanded programme on immunisation (EPI) in May 1974 with 
the objective of vaccinating children throughout the world. The aim of the Expanded 
Programme on Immunisation in South Africa (EPI-SA) is to prevent death and reduce 
suffering from infections that can be prevented by immunisation of children and women 
(DOH 2010:3). The schedule of the programme up to 18 months makes the follow-up of 
all babies and children, including the HIV-exposed, possible. This programme is a good 
platform for management of HIV-exposed children. 
 
The programme has been reviewed over the years for improvement. In 2002, when no 
progress in the implementation of the EPI programme was observed, the WHO and its 
partners devised an innovative strategy, called Reach Every District (RED), to improve 
the implementation (Ryman, McCauley, Nshimirimana, Taylor, Shimp & Wilkins 
2005:18). The strategy has five components, namely effective planning, reaching target 
populations, supportive supervision, monitoring for action, and linking services with 
communities.  
 
In their evaluation of the strategy, Ryman et al (2005:18) found that evaluation of the 
RED implementation process provided evidence of improvement in delivery of routine 
immunisation services. The RED framework should continue to be used to strengthen 
the immunisation delivery system to meet continuing new demands, such as the 
introduction of new vaccines and integrated delivery of other child survival interventions. 
Some of these child survivals are follow-up of HEI and excluding MTCT of HIV. 
 
2.8 HEALTH SYSTEMS STRENGTHENING 
 
The WHO (2007:2) states that it will be impossible to achieve national and international 
goals – including the Millennium Development Goals (MDGs) – without greater and 
more effective investment in health systems and services. The fourth MDG is reduction 
in infant and under-five mortality rates. This systems framework has been blended into 
the conceptual underpinning of the study.  
 
According to the framework, a health system consists of all organisations, people and 
actions whose primary intent is to promote, restore or maintain health. The health 
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system is therefore more than the pyramid of publicly owned facilities that deliver 
personal health services, but an interrelationship of different sub-systems (WHO 
2007:2) (see figure 2.1). The WHO (2007:2) defines overall health system outcomes or 
goals as improving health and health equity, in ways that are responsive, financially fair, 
and make the best, or most efficient, use of available resources.  The relationship to the 
study is that it looks at utilisation of available resources (EPI and IMCI) to manage HEI. 
 
2.8.1 Health systems building blocks 
 
According to the Health Systems Framework (WHO 2007:3), a well-functioning health 
system is built on six blocks:  (1) good health services, (2) a well-performing health 
workforce, (3) a well-functioning health information system, (4) access to essential, 
medical products, vaccines and technologies, (5) a good health financing system, and 
(6) leadership and governance. This framework has been minced into the conceptual 
framework to illustrate that systems equilibrium as opposed to disequilibrium will render 
systems, namely the facilities in the case of this study, effective particularly in regard to 
paediatric HIV management and EPI and IMCI. 
 
 
Figure 2.1 WHO Systems Framework 
(Adapted from WHO 2007:3) 
 
2.8.2 Relationship between programmes and systems  
 
In a study in Zimbabwe on the implications of HIV and AIDS programmes on health 
systems, Chevo and Bhatasara (2012:10) found a strong multidimensional relationship 
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between the programmes and the health systems. Chevo and Bhatasara (2012:10) 
indicate further that although there is agreement that stronger health systems are 
needed to achieve improved outcomes in HIV and AIDS programmes, there is no 
consensus on how to strengthen health systems to cope with the expanded 
programmes. 
 
This study sought to understand the utilisation of the services as influenced by some 
factors within the system in the selected facilities.  The purpose was to gain a deeper 
understanding of the factors affecting the utilisation of EPI and IMCI in follow up and 
management of childhood illnesses as it is lived by the staff members selected for the 
study. 
 
2.9 RELATIONSHIP OF THE SYSTEMS, PMTCT, IMCI AND EPI IN RESPONSE 
TO MDG4 
 
The aim of the Expanded Programme on Immunisation in South Africa (EPI-SA) is to 
prevent death and reduce suffering from infections that can be prevented by 
immunisation of children and women (DOH 2010:3). The schedule of the programme up 
to 18 months makes the follow-up of all babies and children, including the HIV-exposed 
ones, possible. This programme is a good platform for management of HIV-exposed 
children. This links with the study mentioned in paragraph 2.8.2 on multidimensional 
relationship between health systems and programmes. The study at hand examined the 
factors in the health systems that affect the utilisation of EPI and IMCI programmes in 
the follow-up of HIV-exposed babies and the antibody testing at 18 months. This was 
based on the meaning and interpretation of the nurses on the link between the health 
systems in which the services take place.  
 
Afran, Garciaknight, Nduati, Urban, Heyderman and Rowland-Jones (2013:11) found 
that through the successful implementation of policies to prevent mother-to-child-
transmission (PMTCT) of HIV infection, children born to HIV-1-infected mothers are now 
much less likely to acquire HIV infection than previously. Nevertheless, HIV-exposed 
uninfected (HEU) children have a substantially increased morbidity and mortality 
compared to children born to uninfected mothers. Afran et al (2013:11), however, 
question whether improved maternal and child care and ART regimens during and after 
pregnancy together with optimised infant immunisation schedules can be expected to 
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reduce the excess morbidity and mortality of HEI.  This question is relevant in the 
present study. 
 
Lambrechts, Bryce and Orinda (1999:592) point out that incorporating IMCI into ongoing 
district and national efforts to improve child health, and linking it with other health 
initiatives (e.g. safe motherhood initiative) will facilitate meeting the objectives of the 
MDG4. Understanding the nurses’ perspective on utilisation of IMCI to achieve the 
targets as set out in PMTCT guidelines in line with the MDG4, would give the 
researcher the information to come to a conclusion in the study. Therefore the 
researcher wished to gain an insight into the interpretation and meaning of the utilisation 
of the EPI and IMCI to follow-up and test HEI at 18 months as experienced by facility 
managers and nurses in these programmes. 
 
2.10 CONCLUSION 
 
This chapter discussed the literature review conducted for understanding the utilisation 
of EPI and IMCI for paediatric HIV management. The literature review covered the 
PMTCT programme; management of HIV-exposed infants and infant mortality; the 
importance of integrating paediatric HIV management into EPI and IMCI, and the global 
and South African response to the call for reduction of mother-to-child transmission of 
HIV. Although limited, especially with regard to the South African context, the literature 
reviewed illustrated similar perspectives on integrating paediatric management services 
for the prevention of child mortality. 
 
Chapter 3 describes the research design and methodology.  
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CHAPTER 3 
 
RESEARCH DESIGN AND METHODOLOGY 
 
3.1 INTRODUCTION  
 
This chapter describes the research design and methodology used in the study, 
including the site and participant populations, sampling, data collection, trustworthiness 
and ethical considerations. The study used an interpretative hermeneutic 
phenomenological qualitative design. 
 
The objectives of this study were to: 
 
• Have an understanding of available services in the facilities selected for the 
study. 
• Determine the meaning and interpretation by facility managers and nurses of the 
utilisation of EPI and IMCI programme for follow-up and antibody testing of HEIs 
at 18 months. 
• Interpret the systems and factors influencing follow-up and management of HEIs 
as experienced by EPI and IMCI facility managers and nurses. 
 
The findings of the study should add to the knowledge on the subject and create a 
platform to base reorganisation of the facilities and services for efficiency in the 
management of HEIs. 
 
3.2 RESEARCH DESIGN 
 
A research design is a blueprint for conducting a study in such a way that factors that 
could interfere with the validity of the findings are controlled (Polit & Beck 2008:24). A 
good design helps a researcher to avoid bias while collecting information. The study 
used a qualitative, interpretive hermeneutic phenomenological design. 
 
A qualitative study is an investigation of a phenomenon in an in-depth and holistic 
fashion through a collection of rich narrative materials, using a flexible design (Polit & 
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Beck 2008:763). In qualitative research the study of humans from a philosophical point 
of view is deeply rooted in descriptive modes of science (Streubert & Carpenter 2011:3) 
The enquirer seeks in-depth understanding by collecting narrative information from the 
people experiencing a phenomenon which will be analysed qualitatively. The 
relationship of the researcher and the subject of research in this paradigm are 
interactive. The researcher encouraged participative interaction of the participants. 
 
Interpretive phenomenology stresses interpreting and understanding, not just describing 
human experience. The focus of phenomenological inquiry, then, is the meaning of 
people’s experience of a phenomenon, and how those experiences are interpreted 
(Polit & Beck 2004:253). The purpose of this study was to identify the facility managers 
and nurses’ meaning and interpretation of the utilisation of EPI and IMCI programmes 
for follow-up and antibody testing of HEIs at 18 months in Steve Tshwete sub-district of 
Nkangala district in Mpumalanga province.  
   
Denzin and Lincoln (1994) (cited in Streubert & Carpenter 2011:4) and Rose, Beeby 
and Parker (1995:1124) (cited in Streubert & Carpenter 2011:78) state that 
phenomenology as a research methodology is rigorous and its purpose is to get the 
structure or essence of the lived experience of a phenomenon.  The researcher 
selected the design for the purpose of understanding factors in the health systems that 
influence management of HEI. The study involved an in-depth investigation of the 
situation in the EPI and IMCI programmes in relation to follow-up and management of 
HIV-exposed babies.  
 
3.3 RESEARCH METHODOLOGY 
 
3.3.1 Sampling 
 
Selecting a group of people, events, behaviours, or any other elements with which to 
conduct a study is known as sampling. A sample is intended to acquire a representative 
portion of the population (Burns & Grove 2005:341). Phenomenology is a qualitative 
research tradition, with roots in philosophy and psychology, which focuses on the lived 
experience of individuals (Polit & Beck 2012:737). In phenomenology, non-probability, 
purposive sampling is most commonly used to select individuals based on their 
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particular knowledge of the phenomenon (Streubert & Carpenter 2011:90).  Qualitative 
research uses small non-random samples (Polit & Beck 2008:353).  
 
The number of participants in a qualitative study is adequate when saturation of 
information is achieved. Data saturation refers to when themes and categories in the 
data become repetitive and redundant, such that no new information can be obtained 
through further data collection(Polit & Beck 2008:70).  
 
In this study, the researcher used purposive sampling to select specific, readily 
available participants who met the inclusion criteria. 
 
3.3.1.1 Site sampling 
 
The setting for qualitative research is the field; in other words, the place where the 
individuals of interest live and experience life (Streubert & Carpenter 2011:27). The 
researcher purposively selected six of the thirteen facilities in Steve Tshwete sub-
district. These facilities were representative of the sub-district as all thirteen render all 
relevant PHC services, including EPI and IMCI.  
 
Multistage/cluster sampling is done in successive stages (Polit & Beck 2004:298). First 
the researcher selected Steve Tshwete sub-district from the Nkangala district. Then 
from the thirteen facilities, two were selected from the urban (residential) area, two from 
the suburban (residential) area, one from the farms, and one from town (non-
residential). This allowed a representative sample of all the facilities in Steve Tshwete. 
To be included in the study, the facilities had to offer a PHC package which includes 
EPI and IMCI services. The facilities were agreed upon with the sub-district 
management.  
 
3.3.1.2 Population sampling 
 
Eligibility or inclusion criteria refer to specified population characteristics used by a 
researcher to select subjects for participation in a study (Burns & Grove 2005:342; Polit 
& Beck 2008:338). The researcher purposively selected people who had lived 
experience of the services.  To be included in the study, participants had to be  
 
  
25 
• facility managers in the selected facilities for at least a year 
• professional nurses in the selected facilities and working in the EPI and IMCI 
services for at least a year 
• willing to participate voluntarily and give consent 
 
Nurses who had worked in the facilities for less than a year or were not willing to give 
consent were excluded. The purpose of sampling was to obtain information-rich 
participants. The total number selected was 18; in the end 16 were interviewed. 
 
Table 3.1 Site and participant samples 
 
Facility number  Name of facility Number of participants 
01  Facility  1 3 
02  Facility 2 3 
03  Facility 3 3 
04  Facility 4 2 
05  Facility 5 2 
06  Facility 6 3 
Total 16 
 
 
3.4 ETHICAL CONSIDERATIONS 
 
Ethics refers to a system of moral values that is concerned with the degree to which 
research procedures adhere to professional, legal and social obligations to the study 
participants (Polit & Beck 2008:753). The researcher observed the ethical 
considerations of obtaining permission to conduct the study; protecting the rights of the 
respondents, and maintaining research objectivity and integrity.  
 
3.4.1 Ethical clearance and permission 
 
To protect the rights of the institution, the researcher obtained ethical clearance and 
permission from the research ethics committees of UNISA (see Annexure A) and 
Mpumalanga province (health) (see Annexure D). Permission from the District and Sub 
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District was sought with a letter written to the District (see Annexure C) (Polit & Beck 
2008:184). The researcher sent this letter and attached the permission from the 
Mpumalanga ethics committee to the sub-district supervisors and managers to notify 
them of the study and the process to be followed (see Annexures C and D). This was 
done to ensure that the study met all the ethical requirements.  
 
3.4.2 Protection of participants 
 
The protection of the rights of the participants was a priority. The participants were 
informed about the purpose of the study, its risks and benefits, and that their responses 
would remain totally anonymous (see Annexure E). In addition, the respondents were 
informed that participation was voluntary and they could drop out at any point if they 
wished to do so (Streubert Speziale & Carpenter 2011:62). This ensured that their rights 
to self-determination and full disclosure remained protected.  
 
The respondents were given all the details of the study and asked to sign an informed 
consent form as confirmation that they had been provided with relevant information and 
were participating voluntarily. 
 
Though the facilities included in the study are known by the district and provincial 
management, care was taken to protect the participants’ identities. The researcher 
ensured the participants’ confidentiality (Streubert Speziale & Carpenter 2011:91). 
 
3.4.3 Research objectivity and integrity 
 
The researcher strove to maintain objectivity and integrity with no plagiarism in the 
conduct of the study. This implied adhering to the highest technical standards and 
indicating the limits to findings, the methodological constraints that determine the 
validity of such findings, and at the conclusion of the study, reporting the findings 
fully and not misrepresenting the results in any way. To the best of their ability, 
researchers should disclose details of theories, methods and research designs that 
might be relevant to interpretations of the findings (Mouton 2001:240). 
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3.5 DATA COLLECTION  
 
Data was collected from 24 to 28 March 2014.  The sub-district managers assisted the 
researcher by informing the facility managers beforehand that the researcher would be 
visiting the clinics to collect data for the study. The researcher negotiated with the 
participants to use their lunch times and other free times to participate. As they had 
already been briefed, they accepted. The facility managers made a quiet room which 
was not in use available for interviews. The facility managers introduced the researcher 
to the staff, especially the potential participants. The facility managers also informed the 
nurses - as they had already been briefed − that the sub-district and district were aware 
of the study, and that participation was voluntary. 
 
The researcher established rapport with the facility personnel to gain their trust. The 
whole study was explained to the participants, including that in addition to writing the 
responses, a tape-recorder would be used for accuracy. Informed consent was signed 
before commencement of the interview. After this, the grand tour question was posed to 
open the field. The interview was conducted in privacy.  
 
Hermeneutic phenomenology is designed to unveil otherwise concealed meanings in 
the phenomena (Streubert Speziale & Carpenter 2011:84). To unveil this concealed 
meaning, the researcher had to move backward and forward using an inquiring mind in 
the gathering of data to get rich information from the participants. The aim was to first 
get the richness of the participants’ experience and unveil and interpret the factors 
within the systems that affect the utilisation of the Expanded Programme on 
Immunisation and the Integrated Management of childhood illnesses services for 
identification and management of HIV exposed infants. 
 
Streubert Speziale and Carpenter (2011:91) refer to Morse’s (1989) statement that 
saturation is a myth. This means that depending on different times and different groups 
and settings, more information can be generated. This was taken care of in the 
selection of the sample. Purposive selection ensures that knowledgeable people are 
selected as respondents. Data was collected until saturation occurred. The number of 
participants selected was 3 per facility which meant 18 participants As the researcher 
continued with the inquiries, it became evident that in the end there was a lot of 
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repetition and the researcher decided saturation had been achieved as there were no 
new themes emerging after 16 had been interviewed(Table 3.1).   
 
3.5.1 Data-collection approach and method 
 
The researcher personally collected the data by means of probing interviews. This 
method was chosen because it is the most powerful method of securing information 
since the interviewer met the respondents face-to-face and collected data from them 
(Polit & Beck 2008:369; Babbie 2007:257). To add to the richness of data, a tape 
recorder was used to gather information verbatim in addition to handwritten information 
field notes so that no information was lost.  The participants were assured that this 
would not be accessible to any person other than the researcher and supervisor on 
request.  
 
Interviews are costly and not anonymous, and can lead to interviewer bias (Polit & Beck 
2008:424). Interviews rather than questionnaires were chosen for one-on-one contact 
as well as the opportunity to probe and clarify, if necessary. The interview started with a 
grand tour question: “What is your experience of the utilisation of EPI and IMCI 
programmes for follow up and antibody testing of HEIs in your facility”? This was 
followed by a series of open ended questions.  Open ended interviewing allowed the 
researcher to follow the participants’ lead. Care was taken during data collection from 
the facility managers and frontline nurses to be sensitive and flexible while probing.  
 
According to Streubert Speziale and Carpenter (2011:90), the participants can be 
helped to explain in detail. This was done without jeopardising the quality of data 
collected. While the interview was conducted, emerging themes were categorised into 
common themes. Data analysis commenced with data collection (see chapter 4 for full 
discussion). 
 
3.5.2 Data-collection instrument 
 
The data-collection instrument for this study was an interview schedule. The researcher 
developed the research interview schedule (see Annexure F). The researcher 
requested colleagues who are conversant with PMTCT and Paediatric HIV 
management (programme officers, programme managers and coordinators) who 
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provide technical support to the MCWH department to review it. It was later reviewed by 
the Department of Health Studies of the University of South Africa (UNISA) and finally 
reviewed by the district research ethics committee. The schedule was meant to give the 
researcher an understanding of the setting to enhance probing questions. As themes 
emerged, the researcher moved backward and forwards the schedule to probe further 
till saturation could be achieved 
 
The anonymity of the facilities was ensured by not revealing the identity, but using 
numbers which only the researcher could attach to the facilities. The schedule was 
divided into two sections. The first section collected information from the facility 
manager to understand the systems issues in the facilities that influence the utilisation 
of the EPI and IMCI services as experienced by the participants. 
 
The second section gathered in-depth information from the facility managers and 
professional nurses working in these services in the selected facilities. The researcher 
wished to gain an understanding of facility managers and nurses’ meaning and 
interpretation of the utilisation of EPI and IMCI programmes for follow-up and antibody 
testing of HEIs at 18 months in Steve Tshwete sub-district of Nkangala district. 
 
3.6 MEASURES TO ENSURE TRUSTWORTHINESS 
 
The strategies of credibility, transferability, dependability and confirmability for 
establishing trustworthiness were taken into consideration (Polit & Beck 2008:537; 
Rossouw 2003:178; Streubert Speziale & Carpenter 2011:47). The researcher ensured 
that the data collected and information generated can be used for enriching the health 
practice; in this case, utilisation of EPI and IMCI programmes for follow-up of HIEs and 
antibody testing and relevant management of these babies. 
 
3.6.1 Credibility 
 
Credibility refers to the extent to which those who read a research report can believe 
and accept the findings to be true (Lincoln & Guba 1985:301). One of the best ways 
to establish credibility is through prolonged engagement with the subject matter. 
Prolonged engagement is essential for building trust and rapport with the 
participants, which in turn makes it more likely that useful, accurate and rich 
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information will be obtained (Polit & Beck 2008:196). The researcher spent time with 
the facility personnel to engage effectively until saturation occurred. 
 
3.6.2 Dependability 
 
Dependability of qualitative data refers to the stability of data over time and over 
conditions (Polit & Beck 2008:538). Dependability is met once researchers have 
demonstrated the credibility of the findings (Streubert Speziale & Carpenter 
2007:38). The transcribed interviews and data analysis were scrutinised by an 
external reviewer, namely the study supervisor.  
 
3.6.3 Transferability 
 
Transferability refers to the probability that the study findings have meaning to others 
in similar situations (Streubert Speziale & Carpenter 2011:39). The researcher 
envisaged the findings being used to enrich knowledge of staff and improve 
management of HEIs in Steve Tshwete sub-district and elsewhere.  
 
3.6.4 Confirmability 
 
Confirmability is a process criterion. Polit and Beck (2008:539), it refers to objectivity 
that is the potential for congruence between two or more independent people about 
the accuracy of data. Researchers document the confirmability of findings by leaving 
an audit trail, which is a recording of activities over time that others can follow. The 
objective is to illustrate as clearly as possible the evidence and thought processes 
that led to the conclusions. By so doing, this study met the criterion of confirmability 
(Streubert Speziale & Carpenter 2007:38). An audit trail was established by keeping 
the interview transcripts, data reduction and analysis products, notes from member 
checks, materials relating to intentions and dispositions, and drafts of the final report. 
 
3.7 CONCLUSION 
 
This chapter discussed the research design and methodology used in this study, 
including sampling, data collection and analysis, reliability and validity, and ethical 
considerations. 
 
Chapter 4 presents the data analysis and interpretation, and the results. 
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CHAPTER 4 
 
DATA ANALYSIS AND INTERPRETATION, AND RESULTS 
 
4.1 INTRODUCTION  
 
Chapter 3 described the research design and methodology, including the study 
population, sample and sampling, data collection, validity and reliability of the research 
instrument, and ethical considerations. This chapter presents the data analysis and 
interpretation, and results from the in-depth interviews. Data analysis and interpretation 
was done together with literature control.  
 
4.2 OBJECTIVE OF THE STUDY 
 
The purpose of the study was to determine the meaning and interpretation of the use of 
the EPI and IMCI programmes for follow-up and antibody testing of HEIs at 18 months 
by facility managers and nurses at Steve Tshwete sub-district of Mpumalanga district in 
Mpumalanga province. The broad objective of the study was to generate information on 
the factors and systems within the six selected health facilities that may have an 
influence on the follow-up and antibody testing of HEIs.  
 
Data was collected by means of in-depth probing interviews with four facility managers 
and twelve nurses in six facilities rendering EPI and IMCI services in Steve Tshwete 
sub-districts of Nkangala district in Mpumalanga province.  
 
4.3 DATA MANAGEMENT AND ANALYSIS 
 
Data analysis is the systematic organisation and synthesis of data, to make meaning of 
it (Burns & Grove 2005:43). Data analysis in phenomenological interviews starts when 
the interviews start. The method used was coding where narrative information was 
organised according to emerging themes manually. The data was organised while being 
collected. 
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The researcher first concentrated on gaining an understanding of what the data 
conveyed (Streubert Speziale & Carpenter 2011:45). The emerging themes from the 
data collected in the interviews were coded and themes with the same meaning 
organised into clusters. This involved the discovery not only of commonalities across 
subjects but also of natural variation and patterns in the data (Polit & Beck 2008: 515). 
Meaning was validated and discrepancies noted.  Minor themes were incorporated into 
the main themes to avoid having too many confusing themes, without ignoring any data. 
A table of categories and themes was formulated and presented to the supervisor and 
agreement reached on the structure and wording. There were commonalities in the 
information given by both the EPI and IMCI nurses since the two categories work 
interchangeably in both services. The facility managers gave information on the 
systems in which the EPI and IMCI services occur, including the services available (see 
table 3.2). There were similarities in the perception of participants on the flow of HEIs 
from post-delivery visits at three to six days and onwards up to eighteen months. The 
IMCI services were also provided in all the facilities on a daily basis. 
 
4.3.1 Services available  
 
Understanding the services available set the tone for understanding the systems in 
which the EPI and IMCI services take place. The facility managers explained the 
services available in detail. It became clear that post-partum consultations are 
conducted daily in some and twice a week in other facilities.  
 
HIV care and treatment is provided on-site daily in some facilities and off-site in the 
hospital in the others. Though HCT is conducted daily in the facilities, it is conducted by 
lay counsellors. PITC is only done by the nurses when the lay counsellors are not 
available, otherwise babies and carers are sent to counsellors for counselling.  EPI 
services are provided daily in one facility, once a week in one, and two days in four 
facilities (see table 4.1).   
 
The participants indicated that in those facilities where the services were not offered 
daily, drop-in patients were not turned away, but consulted.  
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Table 4.1 Services available 
 
SERVICES FACILITIES AND FREQUENCY PER WEEK 1 2 3 4 5 6 
Post-partum consultation Daily Daily 2 days Daily 2 days 2 days 
HIV care and treatment –
including under 5’s 
Hosp Hosp Daily Daily Hosp Daily 
HCT (including PITC) Daily Daily Daily Daily Daily Daily 
Laboratory Hosp Hosp Hosp Hosp Hosp Hosp 
TB treatment Once Daily Once Daily Daily Once 
Immunisation (EPI) 2 days Daily 2 days Once 2 days 2 days 
HIV-exposed baby follow-up Daily Daily Daily Daily Daily 2 days 
Child survival clinic (IMCI) Daily Daily Daily Daily Daily Daily 
 
Key: hosp: hospital 
 
4.3.2 Qualitative data  
 
This section presents the data from the participants. The participants described the 
meaning and interpretation of their experience in the utilisation of EPI and IMCI 
programmes for follow-up and antibody testing of HEIs at 18 months in Steve Tshwete 
sub-district of Nkangala district in Mpumalanga province. The information gathered was 
categorised into themes and categories based on the findings (see table 4.2). The 
themes and categories below illustrate the perception of nurses of the factors within the 
health systems that affect linking EPI and IMCI to HEI as they experience it. 
 
Table 4.2 Themes and categories from the data  
 
Themes Categories Findings 
4.3.2.1 Identification and 
follow-up of HIV-
exposed babies 
• Poor follow up system 
 
Quote: 
“We sometimes identify babies too 
late when they are brought too late 
to the facility…sometimes they are 
brought by their carers posing a 
problem with consent for testing.”  
Poor record-keeping 
 
Poor link between 
maternity and PHC 
facilities 
 
Patient-related 
weaknesses 
 
Not all stakeholders are 
involved 
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Themes Categories Findings 
4.3.2.2 Referral system • Link between referring and 
referral facility. 
 
Quote: 
“…If there could be a formal link 
between us and the hospital…for 
our mothers who attended ante 
natal here, we usually are able to 
get their status if the discharge note 
is not recorded.” 
There is no back referral 
 
There is no way of 
determining patient’s 
arrival at referral facility 
4.3.2.3 Defaulting • Formal defaulter tracking 
system 
 
Quote: 
“My heart was sore when a baby 
whose mother defaulted and the 
baby was seen after two months 
defaulting tested positive at 7 
months…this mother was from the 
farms and she said: “immobile 
being afikanga” (the mobile had not 
turned up) and she did not have 
money to come to the clinic”. 
No clear system for 
defaulter tracking 
 
Patients shop around 
 
Ward-based outreach 
teams not yet functional 
 
Farm dwellers depend on 
mobile clinic 
 
4.4.2.4 Integration • Mother-baby pair 
 
Quote:  
“…I cried once when one of my EPI 
babies whose mother had tested 
negative at ANC came back for the 
10 months’ visit and tested positive 
when we realised that baby had lost 
weight and we asked the mother to 
test and she tested positive and 
then we did a PCR on the baby 
which turned out positive.”  
In facilities that see 
mother-baby pairs 
integrated, follow-up is 
evident 
 
Some facilities see mother 
and baby separately 
 
4.3.2.5 Stigma and 
discrimination 
• Disclosure to family is a problem 
 
“Sometimes the mothers end up 
mix feeding because they are afraid 
of people asking why they are not 
breastfeeding…I have a painful 
story of a police lady whose baby 
became positive because she mix 
fed her...she was an educated 
woman, afraid to disclose that she 
was positive.”  
 
Patients shop around as 
they are afraid to attend 
clinics where they are 
known, leading to 
defaulting 
 
No active support groups in 
5 of the 6 facilities. 
  
35 
Themes Categories Findings 
4.3.2.6 ART initiations • On- and off-site initiations 
 
“I do initiate babies, but I struggle 
with bloods on very small babies 
and I refer them to Paediatric 
OPD…sometimes our doctor helps 
us.”  
 
“Though I am NIMART trained, I am 
not yet comfortable to initiate 
babies…yes, I will when I am 
comfortable.”  
 
 
Nurses in three of the six 
facilities initiate babies 
above 1 year. 
 
Though nurses initiate 
babies, they are not 
comfortable with taking 
bloods on babies. Patients 
shop around as they are 
afraid to attend clinics 
where they are known, 
leading to defaulting 
 
No active support groups in 
5 of the 6 facilities. 
 
 
4.3.2.1 Identification and follow-up of HIV-exposed babies 
 
The participants expressed some common experiences of the identification of HIV- 
exposed babies within the EPI services. The babies and mothers ideally should visit the 
PHC facility within three to six days’ post-delivery (DOH 2011a:14). . They should have 
a blue form which the Mpumalanga Department of Health has developed to remind 
patients to report at the PHC facility within 6 days, a discharge summary which is written 
in the discharge form torn off the maternity record, and a Road to Health Card. All these 
should ideally have an indication of the baby’s exposure to HIV. Some participants 
mentioned that patients sometimes did not bring the documents or the documents were 
not fully completed and they had to phone the hospital where the mother delivered the 
baby. The participants indicated that this was sometimes time consuming and delayed 
patients, leading to long waiting times. 
 
The participants further indicated that though the province has given facilities a mandate 
to conduct universal testing of babies at 18 months in line with the PITC policy that all 
patients (including 18 month-old babies) entering the service point should be offered 
PITC (DOH 2011a:41), they are usually not brought by their mothers to the facilities. 
This then presented a problem in getting consent since legally only a legal parent can 
sign for the underage child.  If an affidavit is sought, they do not always come back the 
same day, thus delaying testing the baby. In the IMCI services, the participants 
indicated that the IMCI guideline indicates how to identify HIV-exposed and -positive 
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children. According to the participants, sometimes babies who had defaulted were 
identified when already very sick:  
 
“In most cases there is an indication in the documents…mothers  bring their 
babies’ Nevirapine and we then know they are exposed…some patients tear off 
page 7 of the Road to Health Card…some patients say their cards are 
lost…some patients from the farms who have delivered at home do not have any 
documents…sometimes we have to phone the hospital maternity to ask about the 
status thus wasting time.” (F1 EPI) 
 
“The IMCI guideline is very clear on how to identify exposed babies…some 
mothers stay away until baby is ill…we test mothers as proxy if baby’s status is 
not known…sometimes the baby is not brought by the mother thereby delaying 
testing babies…the carers have to bring an affidavit so baby can be tested.” (F2 
EPI) 
 
“We sometimes identify babies too late when they are brought too late to the 
facility…sometimes they are brought by their carers, posing a problem with 
consent for testing.” (F3 EPI) 
 
“We follow-up babies in EPI as per schedule…yes, this is an opportunity to 
identify HIV-exposed babies…the Department and other organisation have 
instructed us to test all babies at 18/12, but sometimes they come with carers 
who cannot give consent…oh...mhh, yes we sometimes...test them and if it is not 
the mother, we tell the carer to ask the mother to come to the clinic so we can 
give the results…if the mother has a phone we phone her to come to the clinic …I 
am not aware of policy on what to do if the mother cannot come, mhh...I think we 
need clarity on this.” (F6 EPI) 
 
4.3.2.2 Referral system 
 
The participants indicated that there was no means of knowing how many patients to 
expect from maternity. Patients just arrived at the clinic. They mentioned that it would 
have been better if the patients had attended antenatal care in their facilities. However, 
often patients were from other antenatal clinics. These patients lead to nurses’ phoning 
the maternity to find out what their status is. The participants indicated that there is no 
back referral from the hospital for patients referred to hospital for initiation. According to 
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the participants, this sometimes delays rendering relevant service to the babies as they 
have to phone the hospital for information, which is not always readily available: 
 
“If there could be a formal link between us and the hospital…for our mothers who 
attended antenatal here, we usually are able to get their status if the discharge 
note is not recorded…generally we know because the mother will tell you…they 
(mothers) usually are cooperative.” (FI EPI) 
 
“Our supporting doctor is very helpful when we consult him…When we send sick 
children to the hospital outpatients department we do not get a back referral note 
…we sometimes phone to find out what happened to these babies.” (F1 IMCI) 
 
4.3.2.3 Nurses’ perception of defaulter tracking system 
 
The participants stated that they used different methods of tracking to follow-up 
patients. These are patients whose PCR warrants immediate response. The participants 
also indicated that some patients default because they do not go to clinics close to 
where they live: 
 
“We do not have a defaulter tracking system…we sometimes use home-based 
carers as we do not have an outreach team here…the nurses sometimes go out 
to trace babies.” (F6 Facility Manager) 
 
“Some women migrate from other provinces or towns because their husbands 
work here, then after delivery they go home, therefore their babies seem like 
defaulters.” (F4 EPI) 
 
“My heart was sore when a baby, whose mother defaulted and the baby was 
seen   after two months’ defaulting, tested positive at 7 months…this mother was 
from the farms and she said the mobile clinic had not turned up and she did not 
have money to come to the clinic.” (F2 EPI) 
 
“Sometimes the patients default because they use a clinic that is not in their 
vicinity, so when they do not have money they cannot come…we see a lot of that 
in IMCI when a baby is brought in because she is not well….” (F2 EPI) 
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“I had a child of 7 years who came to my room not well with granny…I do not 
know whether to call this defaulting…She had never been immunised…they 
came from the farms…we had to do catch up. Baby was ultimately transferred to 
hospital.l” (F2 IMCI)) 
 
“Maybe if we already had ward-based outreach teams functional in the farms they 
could help track our babies or reinforce the health education we give. Maybe 
increasing mobile clinics or making them visit more can curb the defaulters as the 
service will be taken to patients in the farms.” (F1, F3, F6 Facility Managers) 
 
4.3.2.4 Integration 
 
The participants in facilities that treat mother and baby together in EPI expressed their 
ability to conduct HCT to mothers who tested negative through ANC and delivery who 
are breastfeeding. In areas where this is not the case, they stated that sometimes 
babies who had tested PCR negative tested positive post-cessation of breastfeeding: 
 
“I cried once when one of my EPI babies whose mother had tested negative at 
ANC came back for the 10 months visit and tested positive when we realised 
that baby had lost weight and we asked the mother to test and she tested 
positive and then we did a PCR on the baby which turned out positive….” (F2 
EPI) 
 
4.3.2.5 Stigma and discrimination 
 
The participants stated that though stigma did not seem a huge problem, there were still 
signs of stigma amongst the mothers, leading to poor outcomes in management of the 
HIV-exposed babies. This was evident in mothers who did not want to use the clinics in 
their vicinity because people knew them in those facilities. 
 
“Though stigma is lesser, we still see mothers who shop around because they 
are known in a specific clinic…I think stigma is about 75% less…they use our 
clinic because they are known in the clinic near to where they live…the problem 
is when they cannot come, the baby defaults.” (F2 EPI) 
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“Some of our patients prefer to go to the facilities in town where they think they 
are not known…sometimes the mothers end up mix feeding because they are 
afraid of people asking why they are not breastfeeding…I have a painful story of 
a police lady whose baby became positive because she mix fed her baby...the 
painful thing is that she herself said that she knew, she is an educated woman, 
but was afraid as her family did not know that she was positive…I think we need 
more health education.” (F1 EPI) 
 
“In our facility we avoid separating patients by stickers or specific files so that 
they do not feel different.” (F4 Facility Manager) 
 
“Maybe if we had support groups, the stigma would be far less because the 
patients would know each other….” (F5 Facility Manager) 
 
4.3.2.6 Paediatric ART initiation 
 
The participants in facilities where they initiate HIV-positive babies on site, expressed 
satisfaction as they felt mothers and babies could be booked and seen together. They, 
however, cited a gap in that they cannot take bloods on especially less than 1 year-old 
babies. The participants in the facilities that still referred to the hospital for initiation 
expressed dissatisfaction because they sometimes, though rarely, lose these children to 
follow-up: 
 
“I do initiate babies, but I struggle with bloods on very small babies and I refer 
them to Paediatric OPD…sometimes our doctor at the hospital helps us.” (F2 
IMCI) 
 
“Though I am NIMART trained, I am not yet comfortable to initiate babies…yes, I will when I am 
comfortable.”(F5 IMCI) 
 
4.4 DISCUSSION OF FINDINGS 
 
The Department of Health (2011c:14) policy on MTCT states that the programme 
should aim to reduce transmission of HIV from mother-to-child to less than 2% at six 
weeks after birth and less than 5% at 18 months of age by 2016. 
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Furthermore it stresses that, management and leadership should be strengthened to 
coordinate the PMTCT programme and ensure its integration with maternal and child 
health programmes. A study in Malawi on the mortality and health outcomes of HIV-
exposed and -unexposed children in a PMTCT cohort found a high mortality rate at 20 
months among HIV-exposed children (Landes et al 2012:6).  EPI and IMCI are the entry 
point of paediatric management, hence the study aimed at generating information on 
the participants’ meaning and experiences of the utilisation of the services on follow-up 
and management  of HEIs. 
 
The researcher identified six themes that emerged from the data, namely identification 
and follow-up of HIV-exposed children; referral system; defaulting; integration; stigma, 
and on- and off-site ART initiations. Although the facility managers and the EPI and 
IMCI nurses were interviewed separately, their information overlapped very often since 
all the nurses, including the facility managers, worked in both services when the need 
arose. 
 
In their study, Ryman et al (2005:18) found that the RED strategy could be integrated 
and used to strengthen other programmes. Moreover, the re-establishment of outreach 
component of RED provided a strong platform for integrating other health services with 
the immunisation programme. The researcher agrees and is of the opinion that while 
strengthening the integration of management of HEIs into EPI and IMCI, there needs to 
be a link with ward out-based teams which work with the communities. This would 
address not only identifying babies that need to be immunised or antibody tested, and 
also facilitate defaulter tracking. 
 
In a study on using IMCI to introduce other selected programmes, Gouws et al 
(2004:513) found that antimicrobial drugs could improve those programmes.  The 
findings of this study indicate the need to utilise EPI and IMCI for identification and 
follow-up of HIV-exposed infants. Furthermore, IMCI training, including introduction of 
antimicrobial drugs, emphasises supervised clinical practice, and in some settings 
health workers are visited in their facilities shortly after training to reinforce their new 
IMCI skills (Gouws et al 2004:510). In this study, some of the participants stated that 
they did not feel confident enough to initiate babies on ART. To integrate ART initiation 
into the EPI and IMCI services would need not only training, but mentoring, support and 
supervision. 
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For tracking defaulters, the participants stated that ward-based outreach teams (WBOT) 
would help support reaching the community, especially in the rural areas (farms). 
However, these teams had not been rolled-out in their area. Patients from the farms 
depended on mobile clinics which sometimes did not reach them, which led to babies’ 
defaulting immunisation and also HIV management. Linking facilities with these WBOT 
teams would support defaulter tracking, among other things.  
 
Lambrechts et al (1999:592) found that incorporating IMCI into safe motherhood, for 
instance, would be cost effective and efficient.  In this study, the participants in smaller 
facilities where mother and baby are seen in one room pointed out the efficiency and 
need for integration.  
 
The participants indicated that the Road to Health Card, the Department’s blue 
discharge forms and record-keeping in some cases limited the identification and follow-
up of HIV-exposed babies. This was not attributed to lack of guidelines, but to poor 
records and data generation. This finding supports Huicho et al’s (2005:17) finding on 
IMCI in Peru that there was a scarcity of data that could not be attributed entirely to 
programmes. One of the building blocks of health systems strengthening framework is 
information. This study found that poor record-keeping was a problem that impeded 
quality link between hospital and EPI and IMCI services.  
 
Figure 4.1 illustrates missed opportunities for antibody testing of babies at 18 months.  
The PCR positivity is low. Using the number of babies who tested negative as a proxy, 
the number tested at 18 months should be as near as possible to that number. The 
participants stated that the Mpumalanga province policy mandates all facilities to 
conduct antibody testing to all babies at 18 months (universal testing-PITC). If PITC is 
practised closely, all or most 18 month-old EPI babies would be antibody tested for HIV. 
The participants added further that the capacity of nurses’ limited antibody testing of all 
babies at 18 months, hence this task had been shifted to counsellors. This might lead to 
missed opportunities on babies who are not tested. 
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Figure 4.1 EPI and Paeds HIV test data July-December 2013 6 facilities – Steve 
Tshwete sub-district 
(Source: Facility data − Monthly input sheet- July-December 2013) 
Key: F stands for facility  
 
The participants indicated that a number of missed babies were admitted to hospital 
with HIV-related illnesses and some died. Babatunde et al (2011:6) found that HIV- 
infected children need to be identified early so that they are linked with care and 
treatment early, to reduce morbidity and mortality. 
 
Some of the participants indicated that the referral system is one way. There was no 
referral back from the facility referred to, which was usually the hospital.  A study in 
Zimbabwe demonstrated that despite a strong multidimensional relationship between 
the programmes and the health systems, there is no consensus on how to strengthen 
health systems to cope with expanded programmes (Chevo & Bhatasara 2012:10). The 
findings in this study emphasise the need for clarity on the referral and defaulter 
tracking systems. The participants indicated that though they did consult the doctors at 
the hospital and transferred patients, they usually did not get feedback or back referral. 
Though they use community health care workers for tracking, some participants stated 
that they sometimes had to visit patients at home as there is no formal tracking system. 
 
Some of the participants stated that they see mothers and babies separately in the 
postnatal services. One participant related the instance of a mother who had tested 
negative at ANC and at 10 months her baby tested positive PCR. This could have been 
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avoided if the mother had been tested postnatal.  The participant maintained that this 
called for integration of the care of mother and child pair. 
 
Another participant attributed some of the limitations in the programme implementation 
to stigma. She stated that some babies were missed because mothers were afraid to 
disclose their status to family. Again, some mothers attended facilities away from their 
homes as they were afraid of being stigmatised in clinics where they would be 
recognised. Buzdugan et al (2012:7) stress the need for a clear understanding of the 
barriers to paediatric testing, such as stigma and discrimination.  Recommendations 
must be clear on how to tackle the problem of clients and patients with the perception 
that they will encounter stigma or be discrimination. 
 
These findings indicated that both the EPI and IMCI programmes are utilised for follow-
up and antibody testing of HEIs at 18 months in the facilities in Steve Tshwete sub-
district of Nkangala district.  In addition, the participants have a good understanding of 
the policies that guide the management of HEIs in the EPI and IMCI programmes. The 
participants, who work in these programmes, indicated that they perception is that there 
are limiting factors in the system that  impact on efficient integration and utilisation of 
EPI and IMCI programmes for follow-up and antibody testing of HEIs at 18 months. To 
tackle and address these limitations requires a collaborative effort. Based on the 
findings, then, the researcher makes recommendations in this regard (see chapter 5). 
 
4.5 CONCLUSION 
 
This chapter presented the data analysis and interpretation, and discussed the findings. 
Participants’ meaning and interpretation of experiences in follow-up and management of 
HIV-exposed babies up to 18 months were described through themes and categorised 
into strengths and weaknesses indicated by the participants. This chapter accurately 
communicated the lived experiences of the participants. Their perception of the factors 
within the systems that affect utilisation of EPI and IMCI for follow up of HEIs became 
the centre of the findings.  
 
The discussion in this chapter centred on the main findings. The policies and guidelines 
for identification and follow-up of HEI were available for both EPI and IMCI services. 
Poor record-keeping and links between maternity and PHC facilities nevertheless led to 
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poor follow-up of HEIs. Lack of back referral affected the follow-up of babies. The lack 
of formal defaulter tracking systems resulted in loss to follow-up. Lack of integration of 
services and still perceived stigma influenced follow-up and management of these HEIs.  
 
Chapter 5 briefly discusses the conclusions and limitations of the study, and makes 
recommendations for practice and further research.  
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CHAPTER 5 
 
CONCLUSIONS, LIMITATIONS AND RECOMMENDATIONS 
 
5.1 INTRODUCTION 
 
This chapter discusses the conclusions and limitations of the study and makes 
recommendations. The study sample consisted of four facility managers and twelve 
professional nurses working in six selected facilities in Steve Tshwete sub-district in 
Nkangala district, Mpumalanga province in South Africa. All the participants had more 
than one year’s experience in EPI, IMCI.  
 
The purpose of the study was to determine the meaning and interpretation of 
experiences by facility managers and nurses on utilisation of EPI and IMCI of HEIs at 18 
months at the selected health facilities. 
 
The researcher used the conclusions, based on the findings of the study, to answer the 
research question: 
 
What is the meaning and interpretation of factors affecting utilisation of EPI and IMCI for 
follow up and HIV testing of HEI in the Steve Tshwete sub-district facilities as perceived 
by the nurses? 
 
5.2 CONCLUSIONS ON OBJECTIVES  
 
The objectives of the study were: 
 
• To have an understanding of available services in the facilities selected for the 
study. 
• Determine the meaning and interpretation as experienced by facility managers 
and nurses of the utilisation of EPI and IMCI programme for follow-up and 
antibody testing of HEIs at 18 months. 
• Define the systems and factors influencing follow-up and management of HEIs 
as experienced by EPI and IMCI facility managers and nurses. 
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Based on the objectives, the researcher reached the following conclusions:  
 
EPI and IMCI services are crucial in the follow-up and management of HEIs. All the 
participants were conversant with the policies that guide their management of these 
clients. The systems were, however, limiting. For example, the referral system lacked 
formal follow-up from the referring facilities and back referral from the receiving facilities. 
The defaulter tracking system was not formal and led to loss to follow-up and 
sometimes delayed treatment. Another limiting factor was that the ward-based outreach 
teams, comprising community health care workers reporting to a professional nurse, to 
take health to the community are not yet functional for support and task shifting. 
 
Human resource issues also led to delayed treatment is. The participants indicated their 
limitations on taking bloods on smaller babies, leading them to refer them to a higher 
level. This needs intervention to make the EPI and IMCI services efficient for managing 
HEIs. 
 
In some facilities, mother and baby were seen in the same room which enhanced follow 
up of HEIs efficient. In the facilities where they are treated in separate rooms, care was 
found to be inefficient. The findings indicate the need for integration of services for 
efficient follow-up and management of HEIs, using EPI and IMCI services, and the 
importance of mother-child pair for follow-up of HEIs. 
 
In all the facilities, the participants stated that patients shopped around because they 
were afraid to attend nearer clinics where they are known. Thus there are still 
perceptions of stigma. Moreover, some patients were said to be afraid to disclose their 
status to relatives and other patients. Only one of the six facilities had an active support 
group of HIV-positive patients. Support groups are a crucial element which could 
remedy perceived stigma. 
 
The findings emphasise that follow-up and management of HEIs depend on EPI and 
IMCI. Utilising these services by incorporating follow-up and management of HEI will 
reduce infant mortality and create the possibility of reaching the MDG4. This calls for a 
rigorous multidimensional intervention. 
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5.3 LIMITATIONS OF THE STUDY 
 
This study was conducted in six targeted fixed health facilities in Steve Tshwete sub-
district in Nkangala district of Mpumalanga province. The site was purposively selected 
and limited to Steve Tshwete sub-district, hence the findings cannot be generalised to 
the entire province or region. However, they can be locally generalised for the Steve 
Tshwete sub-district. 
 
5.4 RECOMMENDATIONS FOR PRACTICE 
 
Based on the findings, the researcher makes the following recommendations to promote 
utilisation of EPI and IMCI for follow-up and testing and management of HEI: 
 
Provincial and District management 
 
• Reorient the staff in the facilities on all relevant guidelines, including policy on 
referral between facilities and institutions, and make these available in all service 
points.  
• Formalise a defaulter tracking system in the sub-district, district and province and 
communicate it to all facilities. Involve community structures. 
• Implement and fast-track the ward-based outreach team (WBOT) strategy in 
Steve Tshwete. 
• The DOH should consider provision of more mobile clinics for hard-to-reach 
populations and offer clinic services, including ANC. This could be done in 
partnership with private organisations and NGOs already doing similar work. 
 
Nursing profession 
 
• Intensify mentoring of NIMART trained nurses on management of infected babies 
and children, especially taking of bloods on these small children. 
• Emphasise the importance of quality record-keeping. Run quality improvement 
projects in facilities. 
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The service 
 
• Strengthen and roll-out the mother-child pair strategy of addressing maternal and 
child care service to services that are not practising it. 
• Reorientate the Steve Tshwete community through the use of community 
stakeholders, like clinic committees, in campaigns and dialogues on the 
importance of compliance with given visit dates. Also in these campaigns 
address stigma and distribute information, education and communication (IEC) 
material.  
 
5.5 RECOMMENDATIONS FOR FURTHER STUDY  
 
Based on the findings of this study, the researcher makes the following 
recommendations for further research: 
 
• Duplicate this study in other sub-districts and provinces prior to generalisation of 
the research findings.  
• An exploration of social beliefs that influence follow-up, testing and management 
of HEI. 
• An investigation of the knowledge level of the community health care workers, 
who are an important support system for care of HEIs, to address capacity for 
HCT in EPI and IMCI programmes. 
 
5.6 CONCLUDING REMARKS 
 
The importance of integrating the management of HEI into the EPI and IMCI cannot be 
overemphasised. The study found limitations and factors within the system that impact 
on efficient integration and utilisation of EPI and IMCI programmes for follow-up and 
antibody testing of HEIs at 18 months. Some of these are stigma and discrimination, 
poor record-keeping and data management, inefficient referral system, lack of a 
standard defaulter tracking system, and poor integration of HEIs management into EPI 
and IMCI.  
 
Locally, the Department needs to be vigilant and use all available resources to manage 
HEI to meet the MDG 4 of prevention of infant mortality. The recommendations from the 
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study are not exhaustive, but a starting point for efficient utilisation of EPI and IMCI 
programmes for follow-up and antibody testing of HEIs at 18 months. 
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From: Nthabiseng Magagula 
21 Wellwood Manor 
Meyersdal 
Johannesburg South 
To: The Department of Health- Provincial Research Committee 
Dear Sir/Madam, 
Application for Clearance to Conduct a Research Project 
I am a student at UNISA. My student number is:  4658914. My Portfolio was approved 
and I have been given permission to conduct a proposal for a dissertation that I will 
present to the University for my Master’s degree in Nursing Science. The proposal will 
be presented to the University for Ethical Clearance. 
While working for an NGO that was supporting amongst others Steve Tshwete sub 
district in Nkangala District, in one of the quarterly Programme review, it became 
evident that Pediatric case finding and management needs attention. I therefore 
decided that conducting an evidence finding study will open discussions on viewing 
Peds HIV management differently. 
I am requesting permission to conduct the research study in Steve Tshwete Sub District 
of Nkangala District in Mpumalanga province. The proposed study is: ““The utilization of 
the EPI (Expanded Program on Immunization) and IMCI (Integrated Management of 
Childhood illnesses) services for follow up and uptake of 18 month HIV antibody test for 
HEI in 6 facilities in Steve Tshwete in Nkangala District,  Mpumalanga province” 
I would like to conduct the study in six health facilities namely Sr Mashiteng clinic, 
Kwazamokuhle clinic, Pullenshope clinic, Civic clinic, Hendrina clinic and Middelburg 
wellness clinic. The rationale for selecting these facilities is to have a mix of facilities 
through Steve Tshwete.  Also these clinics have a high volume of patients. 
I am writing to seek your permission to conduct this research. I intend to use the verified 
DHIS data from January 2013 to June 2013 to illustrate the situation in the facilities 
pertaining management of HIV exposed infants.  For data on utilization of EPI and IMCI 
services, I intend using the registers utilised and using a short interview schedule that 
will be conducted by me with Professional Nurses working in the mentioned facilities. 
Their permission will be sought and confidentiality will be maintained. The results will be 
presented to the Department at a recommended forum.  For systematic issues, the 
facility managers will also be interviewed. 
The researcher will ensure that services are not disrupted during this study. 
  
 
If you have any questions concerning the study, you can contact me on 0722105551 or 
my UNISA Health Sciences Department Supervisor, Professor Dolamo. Her details are 
as follows:  
Your consideration will be highly appreciated. 
Yours faithfully 
AR Nthabiseng Magagula 
0722105551. 
 
 
 
 
 
 
 
 
 
 
 
 
+27 12 4296213 
E-mail:   dolambl@unisa.ac.za 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Annexure C 
 
A letter to the District Management informing them of 
the study in their clinics 
 
 
 
 
 
 
  
 
From: Nthabiseng Magagula 
21 Wellwood Manor 
Meyersdal 
Johannesburg South 
 
 
To: The Department of Health- Nkangala District 
 
Dear Sir/Madam 
 
Application for Clearance to Conduct a Research Project 
 
I am a student at UNISA. My student number is:  4658914. My Portfolio was approved and I 
have been given permission to conduct a proposal for a dissertation that I will present to the 
University for my Master’s degree in Nursing Science. The proposal will be presented to the 
University for Ethical Clearance. 
 
While working for an NGO that was supporting amongst others Steve Tshwete sub district in 
Nkangala District, in one of the quarterly Programme review, it became evident that Pediatric 
case finding and management needs attention. I therefore decided that conducting an evidence 
finding study will open discussions on viewing Peds HIV management differently. 
 
I am requesting permission to conduct the research study in Steve Tshwete Sub District of 
Nkangala District in Mpumalanga province. The proposed study is: ““The utilization of the EPI 
(Expanded Program on Immunization) and IMCI (Integrated Management of Childhood 
illnesses) services for follow up and uptake of 18 month HIV antibody test for HEI in 6 facilities 
in Steve Tshwete in Nkangala District,  Mpumalanga province” 
 
I would like to conduct the study in six health facilities in the sub district. The rationale for 
selecting these facilities is to have a mix of facilities through Steve Tshwete.  Also these clinics 
have a high volume of patients. 
 
I am writing to seek your permission to conduct this research. I intend to use the verified DHIS 
data from January 2013 to June 2013 to illustrate the situation in the facilities pertaining 
management of HIV exposed infants.  For data on utilization of EPI and IMCI services, I intend 
using the registers utilised and using a short interview schedule that will be conducted by me 
with Professional Nurses working in the mentioned facilities. Their permission will be sought and 
confidentiality will be maintained. The results will be presented to the Department at a 
recommended forum.  For systematic issues, the facility managers will also be interviewed. 
 
The researcher will ensure that services are not disrupted during this study. 
 
  
 
If you have any questions concerning the study, you can contact me on 0722105551 or my 
UNISA Health Sciences Department Supervisor, Professor Dolamo. Her details are as follows:  
 
Your consideration will be highly appreciated. 
 
Yours faithfully 
AR Nthabiseng Magagula 
0722105551 
+27 12 4296213 
E-mail:   dolambl@unisa.ac.za 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Annexure D 
 
Research Ethics Clearance Certificate from  
Mpumalanga Health Department 
 
 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Annexure E 
 
Informed consent form in English 
 
 
 
  
 
 
 
CONSENT FORM TO BE SIGNED BY PARTICIPANTS  
 
Name of Study: “utilization of expanded programme on immunisation (EPI) and 
integrated management of childhood illnesses (IMCI) for tracking and management of 
Human Immunodeficiency Virus (HIV) exposed babies” in six facilities in Steve Tshwete 
sub District in Nkangala district of Mpumalanga province in South Africa.  
 
The informed consent is for facility managers and professional nurses working in the six 
selected facilities in Steve Tshwete of Nkangala district of Mpumalanga province 
rendering EPI and IMCI services. 
 
Main investigator: Ms Anne Rose Nthabiseng Magagula  
 
This informed consent contains an information sheet which provides information related 
to the study (e.g., purpose, method, procedures, risks and benefits, etc.) and the nature 
of the involvement of prospective participants. Its second part is a certificate of consent, 
which should be signed by eligible participants who participate to the study as well as by 
a witness and by the researcher. 
 
PART 1 
 
Dear Participant 
 
My name is Ms Anne Rose Nthabiseng Magagula pursuing my Master of Arts Degree in 
Nursing with the University South Africa (UNISA). The purpose of this letter is to request 
your permission to participate in the study mentioned above. The study is a requirement 
in fulfilment of my studies. The results are also expected to add vital information on the 
factors within the health system in the selected facilities that influence the utilisation of 
the EPI and IMCI programmes for follow up and management of HIV exposed babies at 
18 months. 
 
Please take note of the following before you sign the consent:  
 
a) This study is not part of your daily duties in the facility. 
  
 
b) Your participation to this study is voluntary. You can refuse to participate. You can 
also decide to withdraw at any time, even after you have signed the consent form. 
c) The results of this study will be used for scientific purpose and may be published.  
d) You have been selected by virtue of you working in the selected facilities. 
 
To clarify what I am going to do during the study:  
I am going to ask you questions related to the services you render. The information will 
be kept confidential and no one will expose information received from every participant 
to people who should not see them.  Confidentiality will also be maintained if the results 
of this study are published or communicated to another person or organization. During 
the study and thereafter, only I, my supervisor and the UNISA Ethics Committee will 
have access to the records of this study.  
 
To clarify what I will do with the information you will give to me: 
After all participants are interviewed, all information received will be put together and 
analysed. If this study and those that will follow yield obvious results, these findings will 
be utilized to improve the management HIV exposed babies. It is beneficial for you to be 
part of this study as the results of this study also belong to you and you will need to 
learn more about what was discovered at a later stage. The results of this study will be 
shared with you.  
 
You may now ask any question you want about any aspect of the study you have not 
understood. You may sign the certificate of consent if you accept to participate to the 
study only if you feel you have received all information you needed for getting a better 
understanding of this research. 
 
If you have any further queries related to this study in the future, my contact details are 
as follows:  
Ms Anne Rose Nthabiseng Magagula 
Phone Number: 0722105551 
Alternative number: 0826166771 
 
  
 
PART 11: CONSENT FORM TO BE SIGNED BY PARTICIPANTS: 
 
Name of Study: “utilization of expanded programme on immunisation and integrated 
management of childhood illnesses for tracking and management of HIV exposed 
babies” in six facilities in Steve Tshwete sub District in Nkangala District of 
Mpumalanga province in South Africa. 
 
I have read the information on the aims and objectives of the proposed study and was 
provided the opportunity to ask questions and given adequate time to rethink the issue. 
The aim and objectives of the study are sufficiently clear to me. I have not been 
pressurized to participate in any way.  
 
I understand that participation in this study is completely voluntary and that I may 
withdraw from it at any time and without supplying reasons. I know that this Study has 
been approved by the UNISA Ethics Committee and Nkangala district of the 
Department of Health. I am fully aware that the results of this study will be used for 
scientific purposes and may be published. I agree to this, provided my privacy is 
guaranteed.  
I hereby give consent to participate in this Study.  
..........................................................               ................................................  
Name of participant                                           Signature of participant  
………………………     ……………………..           ………………………………… 
Place                            Date                                                 Witness  
Statement by the Researcher  
I provided written information regarding this study.  
I agree to answer any future questions concerning the study  
I will adhere to the approved protocol.  
..........................................................                           ....................................  
Name of Researcher                                                    Signature  
 ………………………………..………                         ………………………….. 
Place                                                                          Date 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Annexure F 
 
Interview schedule 
 
 
 
  
1 
 
INTERVIEW SCHEDULE: FACILITY MANAGER, EPI AND IMCI NURSES 
The purpose of the study is to get an in depth information on factors that influence the 
utilization of Extended Programme of Immunisation (EPI) and Integrated Management 
of Childhood Illnesses (IMCI) services for tracking and management of Human 
Immunodeficiency Virus (HIV) exposed babies up to the age of 18 months in six 
facilities in Steve Tshwete sub District in Nkangala district of Mpumalanga province in 
South Africa.  The facility manager and the professional nurse working in these facilities 
will be interviewed by the researcher. The information will be analysed to categorise the 
emerging themes to have an in depth understanding of the phenomenon of 
management of HIV exposed infants. 
 
Health facility name.........Civic................................................................................. 
 
Sub-district.....Steve Tshwete.................................................................................. 
 
District. .Nkangala.............................................................................................................  
 
Province....Mpumalanga.................................................................................................... 
 
Date of interview...26 February 2014  
SECTION A:  For the Facility Manager 
SYSTEMS: Available=1 Not available=0 Not applicable= x 
Specific Health Center/Clinic Information (indicate services available at health 
facility) 
Service Check if 
available 
Days/Hours of 
Operation 
1 Antenatal Consultation   2 days- drop in seen 
4 PMTCT Services   2 days-drop in seen 
5 Post-partum consultation   2 days –drop in seen 
7 Maternity (MOU) No Off site- Hospital 
8 HIV Care and Treatment (ART clinic)   Including children 
9 HCT ( including PICT)   Counsellors daily 
10 Laboratory   NHLS daily 
11 TB Treatment   1 day- drop in seen 
12 Immunizations   2 days-drop in seen 
13 Exposed Infant Follow-up   3-6 days, 6/52 then 
monthly 
14 Child Survival Clinic (IMCI)   Daily 
15 Other (Please list) See below 
Facility Manager verbatim: “PCR is done at 6 weeks and Bactrim given. Turnaround 
time is about 4-6 weeks. If positive refer to hospital for initiation for initiation… we do not 
  
2 
initiate small babies... we cannot take blood from them. The doctor in OPD supports us, 
but sometimes we initiate and doctor helps with taking blood… at 18 months we do 
antibody testing… before then when they stop breastfeeding we repeat PCR. Mothers 
from farms default if mobile did not come to the point... I wish we could have more 
mobiles or maybe if the team … outreach was working it would be better.  
SECTION B: FOR EPI and IMCI NURSES 
Grand tour question:  “Can you please give an overview of patient flow of HEI in this 
facility from reception to exit”? 
“Baby is seen at 3 to 6 days after delivery… we look for jaundice and check breast and 
feeding…we check road to health card for status…cord, jaundice…weight 
too…sometimes the page 7 with status is torn off then we know something is 
fishy…Mhh.. they need health education…we do PCR at 6 weeks… if positive refer to 
hospital, for initiation.. but we rarely have positive…baby visit monthly if positive 
otherwise come for immunisation accordingly…If mother on ART and adhering at 6 
weeks we stop Nevirapine, otherwise we continue…at 18 months we do antibody 
testing… consent form is sometimes a problem if bought by care giver…I think stigma is 
still a problem… 
I have a painful story of a police lady whose baby became positive because she mixfed 
her baby...the painful thing is that she herself said that knew, she is an educated 
woman, but was afraid as her family did not know that she was positive… I think we 
need more health education (EPI Nurse) 
Question 1-3 narrative 
Question 4-6- Yes=1 Knowledge of = 1 No=0    
1. Which 
services are 
provided for HIV 
exposed infants 
Well baby clinic 
Sick babies in IMCI 
 
2. How are HIV 
exposed infants 
identified and 
followed up? 
Road to health card 
Mothers report they are on treatment 
If baby is on Nevirapine 
3. How are HIV 
infected infants 
referred for 
HAART? 
Small babies are referred to hospital for doctors initiation using the 
Department referral form 
Bigger children are initiated ion site in the ARV site. They are taken to the 
service 
4. Is there a 
protocol for 
testing HIV 
exposed 
infants?  
Yes 
 
  
No If yes describe the protocol 
- PMTCT 2010 protocol – PCR at 6/52, PCR six weeks after 
cessation of breastfeeding and antibody testing at 18/12 
- Also at 18/12 - Universal testing of the Mpumalanga 
Department of Health 
  
3 
5. Are there 
regular HIV 
exposed follow 
up visits?  
Yes No If yes what services are provided to the infant or mother at that 
visit? 
- All HIV exposed babies are seen monthly or at any time when 
they have a problem. 
- If status is not known, breastfeeding, mother is tested, if 
positive, baby is done PCR. If mother is negative, mother is 
tested every 12 months.  
6. Are the HIV 
screening 
activities 
integrated into 
IMCI, EPI  
Yes No Describe: 
All babies whose mothers test positive and are breastfeeding, 
have PCR test at 6 weeks and PCR six weeks post cessation 
of breastfeeding. At or after 18 months HIV antibody testing is 
done. 
 
 
Data from registers used in the consultation room 
Indicator Month 
1(M1) 
M2 M3 M4 M5 M6 
PHC head count under 5 340 429 468 489 364 257 
Number of PCR infants tested at 6 
weeks 
2 4 2 6 5 0 
Number of PCR infants tested after 6 
weeks 
0 3 0 1-post 
weaning 
0 0 
Number PCR positive 0 0 0 1 0 0 
Number initiated/referred for ART 0 0 0 - 0 0 
Number of Antibody test infants 18 
months  
0 0 0 5 3 0 
Number of Antibody test after 18 months 0 0 0 0 0 0 
Number EPI at 18 months (second 
measles) 
32 19 11 17 19 13 
Number of Antibody test of babies at 18 
months or older positive 
- -  - - - 
Number initiated/referred for ART - -  - -  
 
 
 
Any further comments: 
“More community education is needed so that they stop shopping around. There needs 
to be more support for farm people to get more visits” (Facility manager) 
 
Thank you for your participation. 
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University of South Africa Ethical Clearance Certificate 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Annexure B 
 
A letter to the Department of Health to request authorisation  
to conduct the study 
 
 
 
 
  
 
 
 
From: Nthabiseng Magagula 
21 Wellwood Manor 
Meyersdal 
Johannesburg South 
To: The Department of Health- Provincial Research Committee 
Dear Sir/Madam, 
Application for Clearance to Conduct a Research Project 
I am a student at UNISA. My student number is:  4658914. My Portfolio was approved 
and I have been given permission to conduct a proposal for a dissertation that I will 
present to the University for my Master’s degree in Nursing Science. The proposal will 
be presented to the University for Ethical Clearance. 
While working for an NGO that was supporting amongst others Steve Tshwete sub 
district in Nkangala District, in one of the quarterly Programme review, it became 
evident that Pediatric case finding and management needs attention. I therefore 
decided that conducting an evidence finding study will open discussions on viewing 
Peds HIV management differently. 
I am requesting permission to conduct the research study in Steve Tshwete Sub District 
of Nkangala District in Mpumalanga province. The proposed study is: ““The utilization of 
the EPI (Expanded Program on Immunization) and IMCI (Integrated Management of 
Childhood illnesses) services for follow up and uptake of 18 month HIV antibody test for 
HEI in 6 facilities in Steve Tshwete in Nkangala District,  Mpumalanga province” 
I would like to conduct the study in six health facilities namely Sr Mashiteng clinic, 
Kwazamokuhle clinic, Pullenshope clinic, Civic clinic, Hendrina clinic and Middelburg 
wellness clinic. The rationale for selecting these facilities is to have a mix of facilities 
through Steve Tshwete.  Also these clinics have a high volume of patients. 
I am writing to seek your permission to conduct this research. I intend to use the verified 
DHIS data from January 2013 to June 2013 to illustrate the situation in the facilities 
pertaining management of HIV exposed infants.  For data on utilization of EPI and IMCI 
services, I intend using the registers utilised and using a short interview schedule that 
will be conducted by me with Professional Nurses working in the mentioned facilities. 
Their permission will be sought and confidentiality will be maintained. The results will be 
presented to the Department at a recommended forum.  For systematic issues, the 
facility managers will also be interviewed. 
The researcher will ensure that services are not disrupted during this study. 
 
 
If you have any questions concerning the study, you can contact me on 0722105551 or 
my UNISA Health Sciences Department Supervisor, Professor Dolamo. Her details are 
as follows:  
Your consideration will be highly appreciated. 
Yours faithfully, 
AR Nthabiseng Magagula 
0722105551. 
 
 
 
 
 
 
 
 
 
 
 
 
  
+27 12 4296213 
E-mail:   dolambl@unisa.ac.za 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Annexure C 
 
A letter to the District Management informing them of 
the study in their clinics 
 
 
 
 
 
 
  
 
 
From: Nthabiseng Magagula 
21 Wellwood Manor 
Meyersdal 
Johannesburg South 
 
To: The Department of Health- Nkangala District 
 
Dear Sir/Madam, 
 
Application for Clearance to Conduct a Research Project 
 
I am a student at UNISA. My student number is:  4658914. My Portfolio was approved and I 
have been given permission to conduct a proposal for a dissertation that I will present to the 
University for my Master’s degree in Nursing Science. The proposal will be presented to the 
University for Ethical Clearance. 
 
While working for an NGO that was supporting amongst others Steve Tshwete sub district in 
Nkangala District, in one of the quarterly Programme review, it became evident that Pediatric 
case finding and management needs attention. I therefore decided that conducting an evidence 
finding study will open discussions on viewing Peds HIV management differently. 
 
I am requesting permission to conduct the research study in Steve Tshwete Sub District of 
Nkangala District in Mpumalanga province. The proposed study is: ““The utilization of the EPI 
(Expanded Program on Immunization) and IMCI (Integrated Management of Childhood 
illnesses) services for follow up and uptake of 18 month HIV antibody test for HEI in 6 facilities 
in Steve Tshwete in Nkangala District,  Mpumalanga province” 
 
I would like to conduct the study in six health facilities in the sub district. The rationale for 
selecting these facilities is to have a mix of facilities through Steve Tshwete.  Also these clinics 
have a high volume of patients. 
 
I am writing to seek your permission to conduct this research. I intend to use the verified DHIS 
data from January 2013 to June 2013 to illustrate the situation in the facilities pertaining 
management of HIV exposed infants.  For data on utilization of EPI and IMCI services, I intend 
using the registers utilised and using a short interview schedule that will be conducted by me 
with Professional Nurses working in the mentioned facilities. Their permission will be sought and 
confidentiality will be maintained. The results will be presented to the Department at a 
recommended forum.  For systematic issues, the facility managers will also be interviewed. 
 
The researcher will ensure that services are not disrupted during this study. 
 
If you have any questions concerning the study, you can contact me on 0722105551 or my 
UNISA Health Sciences Department Supervisor, Professor Dolamo. Her details are as follows:  
Your consideration will be highly appreciated. 
Yours faithfully, 
AR Nthabiseng Magagula 
0722105551. 
+27 12 4296213 
E-mail:   dolambl@unisa.ac.za 
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Annexure E 
 
Informed consent form in English 
 
 
 
  
 
 
 
CONSENT FORM TO BE SIGNED BY PARTICIPANTS  
 
Name of Study: “utilization of expanded programme on immunisation (EPI) and 
integrated management of childhood illnesses (IMCI) for tracking and management of 
Human Immunodeficiency Virus (HIV) exposed babies” in six facilities in Steve Tshwete 
sub District in Nkangala district of Mpumalanga province in South Africa.  
 
The informed consent is for facility managers and professional nurses working in the six 
selected facilities in Steve Tshwete of Nkangala district of Mpumalanga province 
rendering EPI and IMCI services. 
 
Main investigator: Ms Anne Rose Nthabiseng Magagula  
 
This informed consent contains an information sheet which provides information related 
to the study (e.g., purpose, method, procedures, risks and benefits, etc) and the nature 
of the involvement of prospective participants. Its second part is a certificate of consent, 
which should be signed by eligible participants who participate to the study as well as by 
a witness and by the researcher. 
 
PART 1. 
Dear participant, 
 
My name is Ms Anne Rose Nthabiseng Magagula pursuing my Master of Arts Degree in 
Nursing with the University South Africa (UNISA). The purpose of this letter is to request 
your permission to participate in the study mentioned above. The study is a requirement 
in fulfillment of my studies. The results are also expected to add vital information on the 
factors within the health system in the selected facilities that influence the utilisation of 
the EPI and IMCI programmes for follow up and management of HIV exposed babies at 
18 months. 
 
Please take note of the following before you sign the consent:  
 
a) This study is not part of your daily duties in the facility. 
b) Your participation to this study is voluntary. You can refuse to participate. You can 
also decide to withdraw at any time, even after you have signed the consent form. 
 
 
c) The results of this study will be used for scientific purpose and may be published.  
d) You have been selected by virtue of you working in the selected facilities. 
 
To clarify what I am going to do during the study:  
I am going to ask you questions related to the services you render. The information will 
be kept confidential and no one will expose information received from every participant 
to people who should not see them.  Confidentiality will also be maintained if the results 
of this study are published or communicated to another person or organization. During 
the study and thereafter, only I, my supervisor and the UNISA Ethics Committee will 
have access to the records of this study.  
 
To clarify what I will do with the information you will give to me: 
After all participants are interviewed, all information received will be put together and 
analysed. If this study and those that will follow yield obvious results, these findings will 
be utilized to improve the management HIV exposed babies. It is beneficial for you to be 
part of this study as the results of this study also belong to you and you will need to 
learn more about what was discovered at a later stage. The results of this study will be 
shared with you.  
 
You may now ask any question you want about any aspect of the study you have not 
understood. You may sign the certificate of consent if you accept to participate to the 
study only if you feel you have received all information you needed for getting a better 
understanding of this research. 
 
If you have any further queries related to this study in the future, my contact details are 
as follows:  
Ms Anne Rose Nthabiseng Magagula 
Phone Number: 0722105551 
Alternative number: 0826166771 
 
PART 11: CONSENT FORM TO BE SIGNED BY PARTICIPANTS: 
 
Name of Study: “utilization of expanded programme on immunisation and integrated 
management of childhood illnesses for tracking and management of HIV exposed 
 
 
babies” in six facilities in Steve Tshwete sub District in Nkangala District of 
Mpumalanga province in South Africa. 
 
I have read the information on the aims and objectives of the proposed study and was 
provided the opportunity to ask questions and given adequate time to rethink the issue. 
The aim and objectives of the study are sufficiently clear to me. I have not been 
pressurized to participate in any way.  
 
I understand that participation in this study is completely voluntary and that I may 
withdraw from it at any time and without supplying reasons. I know that this Study has 
been approved by the UNISA Ethics Committee and Nkangala district of the 
Department of Health. I am fully aware that the results of this study will be used for 
scientific purposes and may be published. I agree to this, provided my privacy is 
guaranteed.  
I hereby give consent to participate in this Study.  
..........................................................               ................................................  
Name of participant                                           Signature of participant  
………………………     ……………………..           ………………………………… 
Place                            Date                                                 Witness  
Statement by the Researcher  
I provided written information regarding this study.  
I agree to answer any future questions concerning the study  
I will adhere to the approved protocol.  
..........................................................                           ....................................  
Name of Researcher                                                    Signature  
 ………………………………..………                         ………………………….. 
Place                                                                          Date 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Annexure F 
 
Interview schedule 
 
 
 
 
1 
 
INTERVIEW SCHEDULE: FACILITY MANAGER, EPI AND IMCI NURSES 
The purpose of the study is to get an in depth information on factors that influence the 
utilization of Extended Programme of Immunisation (EPI) and Integrated Management 
of Childhood Illnesses (IMCI) services for tracking and management of Human 
Immunodeficiency Virus (HIV) exposed babiesup to the age of 18 monthsin six facilities 
in Steve Tshwete sub District in Nkangala district of Mpumalanga province in South 
Africa.  The facility manager and the professional nurse working in these facilities will be 
interviewed by the researcher. The information will be analysed to categorise the 
emerging themes to have an in depth understanding of the phenomenon of 
management of HIV exposed infants. 
 
Health facility name.........Civic................................................................................. 
 
Sub-district.....Steve Tshwete  .................................................................................. 
 
District. .Nkangala.............................................................................................................  
 
Province....Mpumalanga.................................................................................................... 
 
Date of interview...26 February 2014  
SECTION A:  For the Facility Manager 
SYSTEMS: Available=1 Not available=0 Not applicable= x 
Specific Health Center/Clinic Information (indicate services available at health 
facility) 
Service Check if 
available 
Days/Hours of 
Operation 
1 Antenatal Consultation   2 days- drop in seen 
4 PMTCT Services   2 days-drop in seen 
5 Post-partum consultation   2 days –drop in seen 
7 Maternity (MOU) No Off site- Hospital 
8 HIV Care and Treatment (ART clinic)   Including children 
9 HCT ( including PICT)   Counsellors daily 
10 Laboratory   NHLS daily 
11 TB Treatment   1 day- drop in seen 
12 Immunizations   2 days-drop in seen 
13 Exposed Infant Follow-up   3-6 days, 6/52 then 
monthly 
14 Child Survival Clinic (IMCI)   Daily 
15 Other (Please list) See below 
Facility Manager verbatim: “PCR is done at 6 weeks and Bactrim given. Turnaround 
time is about 4-6 weeks. If positive refer to hospital for initiation for initiation… we do not 
 
2 
initiate small babies... we cannot take blood from them. The doctor in OPD supports us, 
but sometimes we initiate and doctor helps with taking blood… at 18 months we do 
antibody testing… before then when they stop breastfeeding we repeat PCR. Mothers 
from farms default if mobile did not come to the point... I wish we could have more 
mobiles or maybe if the team … outreach was working it would be better.  
SECTION B: FOR EPI and IMCI NURSES 
Grand tour question:  “Can you please give an overview of patient flow of HEI in this 
facility from reception to exit”? 
“Baby is seen at 3 to 6 days after delivery… we look for jaundice and check breast and 
feeding…we check road to health card for status…cord, jaundice…weight 
too…sometimes the page 7 with status is torn off then we know something is 
fishy…Mhh.. they need health education…we do PCR at 6 weeks… if positive refer to 
hospital, for initiation.. but we rarely have positive…baby visit monthly if positive 
otherwise come for immunisation accordingly…If mother on ART and adhering at 6 
weeks we stop Nevirapine, otherwise we continue…at 18 months we do antibody 
testing… consent form is sometimes a problem if bought by care giver…I think stigma is 
still a problem… 
I have a painful story of a police lady whose baby became positive because she mixfed 
her baby...the painful thing is that she herself said that knew, she is an educated 
woman, but was afraid as her family did not know that she was positive… I think we 
need more health education (EPI Nurse) 
Question 1-3 narrative 
Question 4-6- Yes=1 Knowledge of = 1 No=0    
1. Which 
services are 
provided for HIV 
exposed infants 
Well baby clinic 
Sick babies in IMCI 
 
2. How are HIV 
exposed infants 
identified and 
followed up? 
Road to health card 
Mothers report they are on treatment 
If baby is on Nevirapine 
3. How are HIV 
infected infants 
referred for 
HAART? 
Small babies are referred to hospital for doctors initiation using the 
Department referral form 
Bigger children are initiated ion site in the ARV site. They are taken to the 
service 
4. Is there a 
protocol for 
testing HIV 
exposed 
infants?  
Yes 
 
  
No If yes describe the protocol 
- PMTCT 2010 protocol – PCR at 6/52, PCR six weeks after 
cessation of breastfeeding and antibody testing at 18/12 
- Also at 18/12 - Universal testing of the Mpumalanga 
Department of Health 
 
3 
5. Are there 
regular HIV 
exposed follow 
up visits?  
Yes No If yes what services are provided to the infant or mother at that 
visit? 
- All HIV exposed babies are seen monthly or at any time when 
they have a problem. 
- If status is not known, breastfeeding, mother is tested, if 
positive, baby is done PCR. If mother is negative, mother is 
tested every 12 months.  
6. Are the HIV 
screening 
activities 
integrated into 
IMCI, EPI  
Yes No Describe: 
All babies whose mothers test positive and are breastfeeding, 
have PCR test at 6 weeks and PCR six weeks post cessation 
of breastfeeding. At or after 18 months HIV antibody testing is 
done. 
 
 
Data from registers used in the consultation room 
Indicator Month 
1(M1) 
M2 M3 M4 M5 M6 
PHC head count under 5 340 429 468 489 364 257 
Number of PCR infants tested at 6 
weeks 
2 4 2 6 5 0 
Number of PCR infants tested after 6 
weeks 
0 3 0 1-post 
weaning 
0 0 
Number PCR positive 0 0 0 1 0 0 
Number initiated/referred for ART 0 0 0 - 0 0 
Number of Antibody test infants 18 
months  
0 0 0 5 3 0 
Number of Antibody test after 18 months 0 0 0 0 0 0 
Number EPI at 18 months (second 
measles) 
32 19 11 17 19 13 
Number of Antibody test of babies at 18 
months or older positive 
- -  - - - 
Number initiated/referred for ART - -  - -  
 
 
 
Any further comments: 
“More community education is needed so that they stop shopping around. There needs 
to be more support for farm people to get more visits” (Facility manager) 
 
Thank you for your participation. 
